<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">56434</article-id><article-id pub-id-type="doi">10.7554/eLife.56434</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>A novel function of R-spondin1 in regulating estrogen receptor expression independent of Wnt/β-catenin signaling</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-177852"><name><surname>Geng</surname><given-names>Ajun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7456-6566</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-177853"><name><surname>Wu</surname><given-names>Ting</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-177854"><name><surname>Cai</surname><given-names>Cheguo</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-177855"><name><surname>Song</surname><given-names>Wenqian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-197858"><name><surname>Wang</surname><given-names>Jiqiu</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-177856"><name><surname>Yu</surname><given-names>Qing Cissy</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7516-7137</contrib-id><email>cissyyu@sibcb.ac.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-175825"><name><surname>Zeng</surname><given-names>Yi Arial</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1898-8099</contrib-id><email>yzeng@sibcb.ac.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences</institution><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution>Medical Research Institute, Wuhan University</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution>Department of Endocrinology and Metabolism, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (SJTUSM)</institution><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution>School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Chinese Academy of Sciences</institution><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Reviewing Editor</role><aff><institution>University of Pennsylvania</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Senior Editor</role><aff><institution>University of Pennsylvania</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>04</day><month>08</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e56434</elocation-id><history><date date-type="received" iso-8601-date="2020-02-27"><day>27</day><month>02</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-07-21"><day>21</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Geng et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Geng et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-56434-v1.pdf"/><abstract><p>R-spondin1 (Rspo1) has been featured as a Wnt agonist, serving as a potent niche factor for stem cells in many tissues. Here we unveil a novel role of Rspo1 in promoting <italic>estrogen receptor alpha (Esr1)</italic> expression, hence regulating the output of steroid hormone signaling in the mouse mammary gland. This action of Rspo1 relies on the receptor Lgr4 and intracellular cAMP-PKA signaling, yet is independent of Wnt/β-catenin signaling. These mechanisms were reinforced by genetic evidence. Luminal cells-specific knockout of <italic>Rspo1</italic> results in decreased <italic>Esr1</italic> expression and reduced mammary side branches. In contrast, luminal cells-specific knockout of <italic>Wnt4</italic>, while attenuating basal cell Wnt/β-catenin signaling activities, enhances <italic>Esr1</italic> expression. Our data reveal a novel Wnt-independent role of Rspo1, in which Rspo1 acts as a bona fide GPCR activator eliciting intracellular cAMP signaling. The identification of Rspo1-ERα signaling axis may have a broad implication in estrogen-associated diseases.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Rspo1</kwd><kwd>Wnt/β-catenin</kwd><kwd>GPCR</kwd><kwd>ERα</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31625020</award-id><principal-award-recipient><name><surname>Zeng</surname><given-names>Yi Arial</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002367</institution-id><institution>Chinese Academy of Sciences</institution></institution-wrap></funding-source><award-id>XDB19020200</award-id><principal-award-recipient><name><surname>Zeng</surname><given-names>Yi Arial</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31530045</award-id><principal-award-recipient><name><surname>Zeng</surname><given-names>Yi Arial</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31830056</award-id><principal-award-recipient><name><surname>Zeng</surname><given-names>Yi Arial</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31861163006</award-id><principal-award-recipient><name><surname>Zeng</surname><given-names>Yi Arial</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81873532</award-id><principal-award-recipient><name><surname>Yu</surname><given-names>Qing Cissy</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31671546</award-id><principal-award-recipient><name><surname>Cai</surname><given-names>Cheguo</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution>National key research and development program of China</institution></institution-wrap></funding-source><award-id>2019YFA0802002</award-id><principal-award-recipient><name><surname>Zeng</surname><given-names>Yi Arial</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002367</institution-id><institution>Chinese Academy of Sciences</institution></institution-wrap></funding-source><award-id>XDA16020200</award-id><principal-award-recipient><name><surname>Zeng</surname><given-names>Yi Arial</given-names></name></principal-award-recipient></award-group><funding-statement>The funders conceived the study, wrote the manuscript and made the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Wnt/β-Catenin independent role of Rspo1 in physiological condition is revealed.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Estrogen and progesterone are the main players in mammary development and the progression of breast cancers (<xref ref-type="bibr" rid="bib20">Hilton et al., 2018</xref>; <xref ref-type="bibr" rid="bib32">Macias and Hinck, 2012</xref>). Both hormones act through their cognate receptors, estrogen receptor (ER) and progesterone receptor (PR) (<xref ref-type="bibr" rid="bib20">Hilton et al., 2018</xref>). The mechanisms of ERα activity have been extensively studied (<xref ref-type="bibr" rid="bib7">Carroll, 2016</xref>). However, the upstream regulation of ERα (<italic>Esr1</italic>) expression is much less understood.</p><p>The mammary gland is an epithelial organ profoundly influenced by estrogen and progesterone. The mammary gland is composed of basal and luminal cells, which can be separated by surface expression of CD24 and CD29/CD49f (<xref ref-type="bibr" rid="bib41">Shackleton et al., 2006</xref>; <xref ref-type="bibr" rid="bib45">Stingl et al., 2006</xref>). ER<sup>+</sup> or PR<sup>+</sup> cells, consisting 30 ~ 50% of luminal cells, can be enriched by surface expression of Sca1 (<xref ref-type="bibr" rid="bib37">Regan et al., 2012</xref>; <xref ref-type="bibr" rid="bib42">Shehata et al., 2012</xref>; <xref ref-type="bibr" rid="bib44">Sleeman et al., 2007</xref>). Hormones exert their mitogenic effects primarily through induction of local growth factors (<xref ref-type="bibr" rid="bib1">Asselin-Labat et al., 2010</xref>; <xref ref-type="bibr" rid="bib3">Brisken et al., 2000</xref>; <xref ref-type="bibr" rid="bib4">Cai et al., 2014</xref>; <xref ref-type="bibr" rid="bib25">Joshi et al., 2010</xref>; <xref ref-type="bibr" rid="bib36">Rajaram et al., 2015</xref>).</p><p>R-spondin1 (Rspo1) has been identified as a hormone-mediated local factor, whose expression is upregulated by estrogen and progesterone (<xref ref-type="bibr" rid="bib5">Cai et al., 2020</xref>; <xref ref-type="bibr" rid="bib4">Cai et al., 2014</xref>). R-spondin protein family (Rspo1-4) have been reported to function as niche factors for adult stem cells in multiple organs (<xref ref-type="bibr" rid="bib17">Greicius et al., 2018</xref>; <xref ref-type="bibr" rid="bib18">Han et al., 2014</xref>; <xref ref-type="bibr" rid="bib35">Planas-Paz et al., 2016</xref>; <xref ref-type="bibr" rid="bib43">Sigal et al., 2017</xref>), and Rspo1 has been implicated as critical growth factor in many in vitro stem cell expansion systems, including intestine, stomach and liver (<xref ref-type="bibr" rid="bib2">Barker et al., 2010</xref>; <xref ref-type="bibr" rid="bib24">Huch et al., 2013</xref>; <xref ref-type="bibr" rid="bib27">Kim et al., 2005</xref>; <xref ref-type="bibr" rid="bib40">Sato et al., 2009</xref>). The role of Rspo1 in Wnt signaling has been extensively studied. Rspo1, through its interaction with its receptors Lgr4/5/6, enhances Wnt signaling by attenuating the turnover of Wnt receptors (<xref ref-type="bibr" rid="bib19">Hao et al., 2012</xref>; <xref ref-type="bibr" rid="bib28">Koo et al., 2012</xref>) and potentiating phosphorylation of the Wnt co-receptor Lrp (<xref ref-type="bibr" rid="bib6">Carmon et al., 2011</xref>; <xref ref-type="bibr" rid="bib13">de Lau et al., 2011</xref>; <xref ref-type="bibr" rid="bib15">Glinka et al., 2011</xref>; <xref ref-type="bibr" rid="bib16">Gong et al., 2012</xref>). In the mammary gland, Rspo1 synergizes with another niche factor, Wnt4, to promote mammary basal stem cell self-renewal (<xref ref-type="bibr" rid="bib4">Cai et al., 2014</xref>). In line with the role of Rspo1 in MaSC regulation, Rspo1 expression is enhanced in the diestrus phase of the estrous cycle and during pregnancy (<xref ref-type="bibr" rid="bib4">Cai et al., 2014</xref>), coinciding with the rise of progesterone level and the expansion of basal stem cells (<xref ref-type="bibr" rid="bib1">Asselin-Labat et al., 2010</xref>; <xref ref-type="bibr" rid="bib25">Joshi et al., 2010</xref>). Our recent study also reported the enhanced Rspo1 expression in estrus, a stage with high estrogen signaling activity (<xref ref-type="bibr" rid="bib5">Cai et al., 2020</xref>). Another role of Rspo1 may exist besides maintaining basal stem cells.</p><p>In this study, we uncover a novel function of Rspo1 distinct from its previously reported role in stem cell regulation. We provide evidence that Rspo1 promotes ERα (<italic>Esr1</italic>) expression in luminal cells of the mammary gland. This action of Rspo1 is through activating G-protein coupled cAMP/PKA pathway, while independent of Wnt/β-catenin signaling. Our data reveal a novel Wnt-independent role of Rspo1, and a new upstream regulatory axis for <italic>Esr1</italic> expression.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Rspo1 induces ERα expression and promotes ERα signaling</title><p>To investigate the potential role of Rspo1 in luminal cells, we isolated primary luminal cells (Lin<sup>-</sup>, CD24<sup>+</sup>, CD29<sup>lo</sup>) by FACS (fluorescence-activated cell sorting), and cultured them in 3D Matrigel in the presence of RSPO1 (0.5 μg/ml) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>). Transcriptome and Gene ontology (GO) analysis identified enrichment of various features, including estrogen receptor activity (<xref ref-type="fig" rid="fig1">Figure 1a and b</xref>). qPCR analysis verified that the expression of ERα signaling target genes, including <italic>Pgr</italic> (progesterone receptor, PR), <italic>Ctsd1</italic> (Cathepsin D1) (<xref ref-type="bibr" rid="bib34">Meneses-Morales et al., 2014</xref>), <italic>and Wisp2</italic> (<xref ref-type="bibr" rid="bib50">Zhang et al., 2012b</xref>) are enhanced in the presence of RSPO1 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Rspo1 enhances Esr1 transcription and ERα signaling activities.</title><p>(<bold>a</bold>) RNA-seq of 3D cultured luminal cells in the presence of RSPO1 (0.5 μg/ml) or vehicle. Increased expression of ERα target genes (<italic>Pgr</italic>, <italic>Greb1</italic>) and <italic>Esr1</italic> were enlisted in heatmap of differentially expressed genes (DEGs). (<bold>b</bold>) GO analysis was conducted on upregulated genes and estrogen receptor activity was enhanced in the presence of RSPO1. (<bold>c</bold>) Sca1<sup>+</sup> luminal cells were FACS-isolated. (<bold>d, e</bold>) qPCR analysis of cultured cells in day two indicating increased expression of <italic>Esr1</italic> (<bold>e</bold>) and its target genes (<bold>d</bold>) in the presence of RSPO1 (0.5 μg/ml). (<bold>f</bold>) E2 (1 μM) treatment was used as positive control indicating the upregulation of <italic>Esr1</italic> and its target <italic>Pgr</italic>. (<bold>g</bold>) Western analysis of cultured cells in day 2 showing increased ERα protein levels after RSPO1 treatment. (<bold>h</bold>) A luciferase reporter driven by the ESR1 promoter was constructed and transfected into HEK293T cells. RSPO1 treatment activated the <italic>ESR1</italic> promoter-luciferase reporter activities in a dose dependent manner. (<bold>d–h</bold>) Data are presented as mean ± s.e.m. of three independent experiments. Student’s t test: ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Rspo1 promotes ERα signaling activities.</title><p>(<bold>a</bold>) Sorted Lin<sup>-</sup>, CD24<sup>+</sup>, CD29<sup>lo</sup> luminal cells were cultured in Matrigel as illustrated. (<bold>b</bold>) qPCR validation indicating increased <italic>Esr1</italic> expression and upregulation of ERα target genes in response to RSPO1 stimulation. (<bold>c</bold>) Sorted Lin<sup>-</sup>, CD24<sup>+</sup>, CD29<sup>lo</sup>, Sca1<sup>+</sup> (ER<sup>+</sup>) or Sca1<sup>-</sup> (ER<sup>-</sup>) luminal cells were cultured with or without the stimulation by RSPO1. <italic>Esr1</italic> transcription increased in ER<sup>+</sup> luminal cells after RSPO1 treatment but not in ER<sup>-</sup> luminal cells. (<bold>b, c</bold>) Data are presented as mean ± s.e.m. Student’s t test: ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>RSPO1 induces <italic>Esr1</italic> expression in a dose-dependent manner in Eph4 cell line.</title><p>(<bold>a</bold>) RSPO1 treatment induced the expression of <italic>Esr1</italic> in a dose-dependent manner. (<bold>b,c</bold>) ERα signaling target genes <italic>Pgr</italic> (<bold>b</bold>) <italic>and Greb1</italic> (<bold>c</bold>) were upregulated dose-dependently in the presence of RSPO1. Data are presented as mean ± s.e.m. Student’s t test: ****p&lt;0.0001, ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig1-figsupp2-v1.tif"/></fig></fig-group><p>To further investigate how Rspo1 regulates ERα signaling, we isolated ER<sup>+</sup> luminal cells (Lin<sup>-</sup>, CD24<sup>+</sup>, CD29<sup>lo</sup>, Sca1<sup>+</sup>) and ER<sup>-</sup> luminal cells (Lin<sup>-</sup>, CD24<sup>+</sup>, CD29<sup>lo</sup>, Sca1<sup>-</sup>) based on Sca1 expression (<xref ref-type="fig" rid="fig1">Figure 1c</xref>), and cultured them in 3D. RSPO1 treatment resulted in the upregulation of ERα targets, <italic>Pgr</italic>, <italic>Ctsd1</italic> and <italic>Wisp2</italic> in ER<sup>+</sup> luminal cells, indicating the further activation of ERα signaling (<xref ref-type="fig" rid="fig1">Figure 1d</xref>). Interestingly, the expression of ERα itself (<italic>Esr1</italic>) is also enhanced (<xref ref-type="fig" rid="fig1">Figure 1e</xref>). In contrast, ER<sup>-</sup> luminal cells did not respond to RSPO1 stimulation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1c</xref>). Estrogen (Estradiol-E2, E2) is one of the few known upstream regulator of <italic>Esr1</italic> (<xref ref-type="bibr" rid="bib12">Chu et al., 2007</xref>; <xref ref-type="bibr" rid="bib26">Kanaya et al., 2019</xref>). Thus, E2 (1 μM) was used as control to show the extent of <italic>Esr1</italic> activation. We found that in this ER<sup>+</sup> luminal cell culture system, RSPO1 elevated the expression of <italic>Esr1</italic> and its target <italic>Pgr</italic> to a level comparable with E2 treatment (compare <xref ref-type="fig" rid="fig1">Figure 1d–e</xref> with <xref ref-type="fig" rid="fig1">Figure 1f</xref>). The upregulation of ERα protein by RSPO1 was confirmed by Western blot analysis (<xref ref-type="fig" rid="fig1">Figure 1g</xref>). This role of RSPO1 was further validated in mouse mammary Eph4 cells. RSPO1 upregulates the expression of <italic>Esr1</italic> and ERα signaling targets <italic>Pgr</italic> and <italic>Greb1</italic> (growth regulation by estrogen in breast cancer 1) in a dose-depending manner (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2a–c</xref>).</p><p>To investigate whether Rspo1 regulates <italic>Esr1</italic> transcription, we utilized a luciferase reporter driven by the proximal promoter (promoter A) of human <italic>ESR1</italic> (<xref ref-type="bibr" rid="bib46">Tanimoto et al., 1999</xref>). We found that RSPO1 can induce luciferase expression in a dose-dependent manner, while the control reporter lacking <italic>ESR1</italic> promoter was not activated in any conditions (<xref ref-type="fig" rid="fig1">Figure 1h</xref>). Together, these data suggest that Rspo1 enhances <italic>Esr1</italic> transcription.</p></sec><sec id="s2-2"><title>Rspo1-induced ERα expression is dependent on Lgr4</title><p>To investigate the mechanisms through which Rspo1 regulates <italic>Esr1</italic>, we first examined which receptor of Rspo1 is involved. qPCR analysis indicated that all three Lgr receptors, Lgr4/5/6 are expressed in basal cells, but only Lgr4 is expressed in luminal cells (<xref ref-type="fig" rid="fig2">Figure 2a</xref>), suggesting that Rspo1 may rely on Lgr4 to signal in luminal cells in the context of <italic>Esr1</italic> induction. Within the luminal compartment, Lgr4 was evenly distributed in ER<sup>+</sup> (Sca1<sup>+</sup>) and ER<sup>-</sup> (Sca1<sup>-</sup>) luminal cells (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). In situ hybridization validated the expression pattern of <italic>Lgr4</italic> in both basal and luminal layers (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). We next investigated whether Lgr4 mediates Rspo1’s action on <italic>Esr1</italic> expression. We generated Lgr4 shRNA and validated its knockdown efficacy in primary luminal cells by qPCR analysis (<xref ref-type="fig" rid="fig2">Figure 2c</xref>). Lgr4 knockdown suppressed the upregulation of <italic>Esr1</italic> induced by RSPO1 (<xref ref-type="fig" rid="fig2">Figure 2d</xref>). In an <italic>ESR1-</italic>luciferase reporter assay using T47D (a human breast cancer cell line), LGR4 knockdown also inhibited the luciferase activities induced by RSPO1 (<xref ref-type="fig" rid="fig2">Figure 2e</xref>). The effect was validated using two different shRNAs (<xref ref-type="fig" rid="fig2">Figure 2e</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Results suggest that Rspo1 relies on Lgr4 to activate <italic>Esr1</italic> expression.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Rspo1 inducing <italic>Esr1</italic> expression is dependent on Lgr4.</title><p>(<bold>a</bold>) qPCR analysis of Lgrs in FACS-isolated basal and luminal cells. <italic>Lgr4</italic>, <italic>Lgr5</italic> and <italic>Lgr6</italic> are all expressed in basal cells, while only <italic>Lgr4</italic> is distinctively expressed in luminal cells with even distribution in Sca1<sup>+</sup> (ER<sup>+</sup>) and Sca1<sup>-</sup> (ER<sup>-</sup>) luminal subpopulations. (<bold>b</bold>) Lgr4 in situ hybridization (in pink) confirming its expression in basal (arrow) and luminal cells (arrowhead). Nuclei were counterstained with hematoxylin (in purple). Scale bar, 20 μm. (<bold>c</bold>) qPCR analysis of <italic>Lgr4</italic> expression in cultured luminal cells indicating successful knockdown by shRNA. (<bold>d</bold>) qPCR analysis of <italic>Esr1</italic> expression in cultured luminal cells indicating that knockdown of <italic>Lgr4</italic> by shRNA counteracts the upregulation of <italic>Esr1</italic> by RSPO1. (<bold>e</bold>) <italic>ESR1</italic> promoter-luciferase reporter assays on T47D cells indicating that knockdown of LGR4 mRNA by shRNA counteracts the upregulation of <italic>ESR1</italic> by RSPO1, while scramble shRNA cannot. Data in (<bold>c–f</bold>) are pooled from three independent experiments and are presented as mean ± s.e.m. Student’s t test: ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05; ns, not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Validation of LGR4 shRNAs knockdown efficiency.</title><p>(<bold>a</bold>) qPCR analysis of <italic>LGR4</italic> expression in T47D cells indicating successful knockdown by shRNA.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig2-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>ERα induction by Rspo1 is independent of Wnt/β-catenin signaling</title><p>As Rspo1 is known for amplifying Wnt/β-catenin signaling, we investigated whether Wnt ligands have a synergistic influence on <italic>Esr1</italic> expression. We first examined Wnt4, a major Wnt ligand in the mammary gland that can activate Wnt/β-catenin signaling (<xref ref-type="bibr" rid="bib4">Cai et al., 2014</xref>; <xref ref-type="bibr" rid="bib36">Rajaram et al., 2015</xref>). The activation of <italic>Axin2</italic> expression indicated that Wnt/β-catenin signaling was activated in primary luminal cell culture in the presence of Wnt4 (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). Wnt4+RSPO1 combination further stimulated <italic>Axin2</italic> expression (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). Intriguingly, addition of Wnt4 alone was ineffective in activating <italic>Esr1</italic> expression in these cells (<xref ref-type="fig" rid="fig3">Figure 3b</xref>), and Wnt4+RSPO1 combination was unable to further increase <italic>Esr1</italic> level compared to RSPO1 alone (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). These results suggest that canonical Wnt signaling may not be involved in this regulatory axis. Furthermore, we used either Wnt3a or a GSK3 inhibitor CHIR99021 (CHIR) to stimulate Wnt/β-catenin signaling in primary luminal cell culture. Although Wnt-signaling activators markedly increased the expression levels of its target gene <italic>Axin2</italic> (<xref ref-type="fig" rid="fig3">Figure 3c</xref>), they could not stimulate <italic>Esr1</italic> expression (<xref ref-type="fig" rid="fig3">Figure 3d</xref>). It is noteworthy that the combination of RSPO1 with CHIR did not further induce <italic>Axin2</italic> level (<xref ref-type="fig" rid="fig3">Figure 3c</xref>), probably due to the Wnt/β-catenin signaling activity induced by CHIR or Wnt3a had reached plateau. In contrast to their stimulating effect to <italic>Axin2</italic>, Wnt3a and CHIR treatment suppressed <italic>Esr1</italic> expression (<xref ref-type="fig" rid="fig3">Figure 3d</xref>), an observation in line with a previous report, in which Wnt/β-catenin signaling represses the expression of luminal differentiation genes, mainly <italic>Esr1</italic> (<xref ref-type="bibr" rid="bib30">Lindley et al., 2015</xref>). Inhibition of the Frizzled receptor using its soluble CRD domain (FzCRD) (<xref ref-type="bibr" rid="bib22">Hsieh et al., 1999</xref>) or stimulating β-catenin degradation using XAV939 (<xref ref-type="bibr" rid="bib23">Huang et al., 2009</xref>) effectively suppressed <italic>Axin2</italic> expression induced by Wnt3a (<xref ref-type="fig" rid="fig3">Figure 3c</xref>), still, they could not suppress <italic>Esr1</italic> upregulation by Rspo1 (<xref ref-type="fig" rid="fig3">Figure 3d</xref>). To further verify, we used HEK293T cells transiently expressing <italic>ESR1</italic>-luciferase reporter and cultured them in the presence of RSPO1 or RSPO1 in combination with XAV939 or IWP2. Consistently, inhibition of WNT signaling did not affect <italic>ESR1</italic> promoter activities induced by RSPO1 (<xref ref-type="fig" rid="fig3">Figure 3e and f</xref>). Together, these data suggest that Rspo1 induces ERα expression independent of Wnt/β-catenin signaling.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Esr1</italic> expression induced by Rspo1 is independent of Wnt/β-catenin signaling.</title><p>(<bold>a–b</bold>) qPCR analysis of cultured luminal cells indicating that Wnt4 alone or in combination with RSPO1 can activate Wnt target <italic>Axin2</italic> expression (<bold>a</bold>). While RSPO1 alone promoted <italic>Esr1</italic> expression, Wnt4 was ineffective for <italic>Esr1</italic>. Combination of RSPO1 and Wnt4 displayed no difference compared with RSPO1 alone (<bold>b</bold>). (<bold>c–d</bold>) qPCR analysis of cultured luminal cells indicating that Wnt signaling activators (Wnt3a and GSK3β inhibitor CHIR) cannot activate <italic>Esr1</italic> expression, and that <italic>Esr1</italic> expression induced by RSPO1 cannot be suppressed by addition of Wnt signaling inhibitor (FzCRD or β-catenin inhibitor XAV939) (<bold>d</bold>). In contrast, Wnt-target gene <italic>Axin2</italic> expression was activated in the presence of Wnt signaling activators, and was suppressed by adding the signaling inhibitors (<bold>c</bold>). (<bold>e–f</bold>) HEK293T cells with transiently expressing <italic>ESR1</italic>-luciferase reporter were cultured in the presence of RSPO1, or in combination with Wnt inhibitors (XAV939 and IWP2). Wnt inhibitors cannot suppress <italic>ESR1</italic>-luciferase activities induced by RSPO1. Data in (<bold>a–f</bold>) are pooled from more than three independent experiments and presented as mean ± s.e.m. Student’s t test. ****p&lt;0.0001, ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05; ns, not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig3-v1.tif"/></fig></sec><sec id="s2-4"><title>Loss of luminal Rspo1 results in decreased ERα expression in vivo</title><p>To investigate the role of Rspo1 in vivo, we generated a conditional <italic>Rspo1</italic> knockout allele in which the second <italic>Rspo1</italic> exon is subjected to removal upon <italic>Cre</italic> recombination, resulting in frame-shift of the remaining exons (<xref ref-type="fig" rid="fig4">Figure 4a</xref>, also see <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a–b</xref>). Of note, <italic>Rspo1</italic> is predominantly expressed in ER- luminal cells as described previously (<xref ref-type="bibr" rid="bib4">Cai et al., 2014</xref>), while <italic>Esr1</italic> is expressed in ER<sup>+</sup> luminal cells. Thus, this Rspo1-<italic>Esr1</italic> regulation is likely achieved through a paracrine manner in vivo. A luminal cells-specific BAC transgenic CreER line, <italic>Keratin8-CreER</italic> (<italic>Krt8-CreER</italic>) (<xref ref-type="bibr" rid="bib49">Zhang et al., 2012a</xref>), was used to generate luminal cells-specific <italic>Rspo1</italic> knock-out mice (<italic>Krt8-CreER;Rspo1<sup>fl/fl</sup></italic>) (Rspo1-cKO) (<xref ref-type="fig" rid="fig4">Figure 4b</xref>). Tamoxifen was administered into 8-week-old nulliparous female mice, and mammary glands were examined 4 weeks later. Whole-mount carmine staining showed significantly reduced side branches in Rspo1-cKO mice when compared with the control (<italic>Rspo1<sup>fl/fl</sup></italic>) (<xref ref-type="fig" rid="fig4">Figure 4c and d</xref>). These results are consistent with previous observation in a <italic>Rspo1<sup>-/-</sup></italic> mammary transplantation model (<xref ref-type="bibr" rid="bib10">Chadi et al., 2009</xref>). The knockout efficacy of Rspo1-cKO was validated. ER<sup>-</sup> luminal cells (Lin<sup>-</sup>, CD24<sup>+</sup>, CD29<sup>lo</sup>, Sca1<sup>-</sup>), where Rspo1 is expressed, were isolated (<xref ref-type="fig" rid="fig4">Figure 4e</xref>). <italic>Rspo1</italic> level in cKO group was significantly reduced shown by qPCR analysis (<xref ref-type="fig" rid="fig4">Figure 4f</xref>). By whole-mount immunofluorescence staining, we observed the decreased ERα expression in <italic>Rspo1-cKO</italic> mammary gland (<xref ref-type="fig" rid="fig4">Figure 4g</xref>). Quantification indicated decreased percentage of ERα<sup>+</sup> cells (<xref ref-type="fig" rid="fig4">Figure 4h</xref>), likely reflecting the overall reduction of ERα level in luminal compartment. Although we could not exclude the possible switching of ER<sup>+</sup> to ER<sup>-</sup> cell fate due to other indirectly reasons, we tested a more direct possibility—whether it is the reduction of ERα expression in ER+ compartment that results in loss of ER<sup>+</sup> cells. To this end, we isolated ER+ luminal cells (Lin<sup>-</sup>, CD24<sup>+</sup>, CD29<sup>lo</sup>, Sca1<sup>+</sup>), and analyzed ERα levels as well as ERα signaling activities. We found that ERα levels were reduced in this compartment as shown by qPCR (<xref ref-type="fig" rid="fig4">Figure 4i</xref>) and Western analysis (<xref ref-type="fig" rid="fig4">Figure 4j</xref>). Consistently, ERα signaling target genes, including <italic>Pgr</italic>, <italic>Wisp2</italic> and <italic>Ctsd1</italic> were declined in <italic>Rspo1-cKO</italic> group (<xref ref-type="fig" rid="fig4">Figure 4k</xref>). Therefore, together these results suggest that loss of Rspo1 results in reduced ERα expression and its signaling activities in luminal cells.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Loss of Rspo1 in mammary luminal cells results in reduced side branching and decreased ERα expression.</title><p>(<bold>a</bold>) Schematic illustration of <italic>Rspo1<sup>flox</sup></italic> knock-in allele generation (see also <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). (<bold>b</bold>) <italic>Krt8-CreER;Rspo1<sup>fl/fl</sup></italic> inducible model specifically knockdown Rspo1 in luminal cells. (<bold>c–d</bold>) 8-week-old adult virgin mice were Tamoxifen injected twice, 1 day apart (2 mg/25 g body weight per injection). Mammary glands were obtained 4 weeks later. Whole-mount imaging (<bold>c</bold>) of mammary epithelium and quantification (<bold>d</bold>) showing decreased side branches in Rspo1-cKO mice. n = 3. Scale bar, 2 mm. More than six views were used for quantification. (<bold>e–f</bold>) FACS gating strategy for mammary basal and luminal cell isolation. Luminal ER<sup>+</sup> and ER<sup>-</sup> subpopulations were separated based on Sca1 (<bold>e</bold>). qPCR analyses of luminal cells showing efficient Rspo1 knockdown in <italic>Krt8-CreER;Rspo1<sup>fl/fl</sup></italic> (<bold>f</bold>). (<bold>g–h</bold>) Immunostaining indicated decreased ERα<sup>+</sup> cell number after Rspo1 knockdown (<bold>g</bold>). Scale bar, 40 μm. Quantification of ERα<sup>+</sup> cells were performed in (<bold>h</bold>). (<bold>i</bold>) qPCR analyses of ER<sup>+</sup> luminal cells indicated downregulation of <italic>Esr1</italic> transcription after Rspo1 knockdown in ER<sup>-</sup> cells. (<bold>j</bold>) Sca1<sup>+</sup> (ER<sup>+</sup>) luminal cells were FACS isolated and Western blot was performed to indicate decreased ERα expression after Rspo1 knockdown. (<bold>k</bold>) qPCR analyses of ER<sup>+</sup> luminal cells indicated downregulation of ERα target genes after Rspo1 knockdown in ER<sup>-</sup> cells. Data are presented as mean ± s.e.m. of more than three independent experiments. Student’s t test: ****p&lt;0.0001, ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05. L.N. Lymph node.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Generation of <italic>Rspo1<sup>flox</sup></italic> mouse model.</title><p>(<bold>a</bold>) Targeting strategy to generate the <italic>Rspo1<sup>flox</sup></italic> knock-in (KI) mouse. Design of genotyping primers are as indicated. Exon2 of the <italic>Rspo1</italic> gene was replaced by inserting cassette. (<bold>b</bold>) Pups born from crossing heterozygous male and female mice were genotyped by PCR. Pups with KI allele were identified by the presence of a larger 290 bp band. Genotyping PCR indicated the proper distribution of wild type and heterozygous as Mendel’s law of segregation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Loss of <italic>Lgr4</italic> reduces <italic>Esr1</italic> expression and ERα signaling activities.</title><p>(<bold>a</bold>) <italic>Lgr4<sup>-</sup></italic><sup><italic>/</italic>-</sup> mammary glands display reduced side branches. (<bold>b</bold>) Quantification of side branches was performed in designated area. More than six views were used for quantification. (<bold>c</bold>) Immunostaining of ERα in 8-week-old virgin control and <italic>Lgr4<sup>-</sup></italic><sup><italic>/</italic>-</sup> mammary gland. More than six views were used for quantification. Scale bar, 50 μm. (<bold>d</bold>) Quantification of the proportion of ERα<sup>+</sup> luminal cell among all luminal cells. (<bold>e</bold>) qPCR analysis of ER<sup>+</sup> luminal cells (Lin<sup>-</sup>,CD24<sup>+</sup>,CD29<sup>lo</sup>,Sca1<sup>+</sup>) from mammary gland 1) confirming Lgr4 deficiency in <italic>Lgr4<sup>-</sup></italic><sup><italic>/</italic>-</sup> mammary gland; 2) indicating that <italic>Esr1</italic> expression is significantly decreased in <italic>Lgr4<sup>-</sup></italic><sup><italic>/</italic>- </sup>mammary gland, and 3) reduced ERα targets <italic>Pgr</italic>, <italic>Ctsd1</italic> and <italic>Wisp2</italic>. n = 3 mice. L.N. Lymph node. (<bold>d, e</bold>) Data are presented as mean ± s.e.m. Student’s t test: ****p&lt;0.0001, ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05. ns, not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig4-figsupp2-v1.tif"/></fig></fig-group><p>The <italic>Esr1</italic> expression was also examined in <italic>Lgr4<sup>lacZ</sup></italic> mouse model, a hypomorphic allele of Lgr4, (<xref ref-type="bibr" rid="bib33">Mazerbourg et al., 2004</xref>). Mammary glands of Lgr4 homozygous mutant (<italic>Lgr4<sup>lacZ/lacZ</sup></italic>) were isolated for whole mount imaging. At 9 weeks, <italic>Lgr4<sup>lacZ/lacZ</sup></italic> mammary glands displayed significantly less side branches (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2a–b</xref>). Immunostaining revealed decreased ERα expression in <italic>Lgr4<sup>lacZ/lacZ</sup></italic> mammary gland (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2c–d</xref>). When ER<sup>+</sup> luminal cells (Lin<sup>-</sup>, CD24<sup>+</sup>, CD29<sup>lo</sup>, Sca1<sup>+</sup>) were isolated, we found that <italic>Esr1</italic> was significantly reduced in <italic>Lgr4</italic> mutant, so were the ERα downstream targets <italic>Pgr</italic>, <italic>Ctsd1</italic> and <italic>Wisp2</italic> (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2e</xref>). <italic>Lgr4</italic> expression was markedly decreased in <italic>Lgr4<sup>lacZ/lacZ</sup></italic> mammary gland as a validation of the hypomorphic nature of the allele (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2e</xref>). These results support that Lgr4 plays a role in mediating Rspo1-induced ERα expression.</p></sec><sec id="s2-5"><title>Genetic evidence supports that <italic>Esr1</italic> regulation is independent of luminal Wnt4</title><p>To investigate whether Wnt/β-catenin signaling affects <italic>Esr1</italic> in vivo, we also generated a Wnt4 conditional knockout mouse. In this model, the second <italic>Wnt4</italic> exon is flanked by flox, and is removed upon <italic>Cre</italic> recombination, which leads to frame shift of the remaining exons (<xref ref-type="fig" rid="fig5">Figure 5a</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1a–b</xref>). We generated inducible, luminal cells-specific <italic>Wnt4</italic> knock-out mice (<italic>Krt8-CreER;Wnt4<sup>fl/fl</sup></italic>) (<xref ref-type="fig" rid="fig5">Figure 5b</xref>). Tamoxifen was administered into 8-week-old nulliparous female mice, and mammary glands were examined 4 weeks later. Loss of Wnt4 resulted in reduced side branching (<xref ref-type="fig" rid="fig5">Figure 5c and d</xref>), consistent with a previous report using <italic>MMTV-Cre;Wnt4<sup>fl/fl</sup></italic> model (<xref ref-type="bibr" rid="bib36">Rajaram et al., 2015</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Loss of Wnt4 increases <italic>Esr1</italic> expression in luminal cells.</title><p>(<bold>a</bold>) Schematic illustration of <italic>Wnt4<sup>flox</sup></italic> knock-in allele generation (see also <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). (<bold>b</bold>) <italic>Krt8-CreER;Wnt4<sup>flox</sup></italic> inducible model specifically knockdown Wnt4 in luminal cells. (<bold>c–d</bold>) 8-week-old adult virgin mice were Tamoxifen administered for 2 courses at 1 day apart, 2 mg/25 g body weight per injection and harvested 4 weeks later. Whole-mount imaging of the mammary epithelium showing decreased side branches in <italic>Wnt4</italic>-cKO mice (<bold>c</bold>). n = 3. Scale bar, 1 mm. More than six views were used for quantification. (<bold>e</bold>) qPCR of isolated ER<sup>+</sup> luminal cells validated efficient Wnt4 knockdown in cKO mice. (<bold>f</bold>) qPCR analysis of ER<sup>+</sup> luminal cells indicated Wnt4 loss increased <italic>Esr1</italic> expression levels. (<bold>g</bold>) Western blot analysis indicated increased ERα protein level in <italic>Wnt4</italic>-cKO. (<bold>h</bold>) qPCR analysis of ER<sup>+</sup> luminal cells indicated increased ERα signaling pathway activity after Wnt4 knockdown. (<bold>i</bold>) qPCR analysis of basal cells showed Wnt signaling pathway was decreased after Wnt4 knockdown. Data are presented as mean ± s.e.m. Student’s t test: ****p&lt;0.0001, ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05; ns, not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Generation of <italic>Wnt4<sup>flox</sup></italic> mouse model.</title><p>(<bold>a</bold>) Targeting strategy to generate the <italic>Wnt4<sup>flox</sup></italic> knock-in (KI) mouse. Design of genotyping primers are as indicated. Exon2 of the Wnt4 gene was replaced by inserting cassette. (<bold>b</bold>) Pups born form crossing of heterozygous male and female mice were genotyped by PCR. Pups with KI allele were identified by the presence of a larger 322 bp band. Genotyping PCR indicated the proper distribution of wild type and heterozygous as Mendel’s law of segregation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig5-figsupp1-v1.tif"/></fig></fig-group><p>To address whether loss of Wnt4 affects <italic>Esr1</italic>, we isolated ER<sup>+</sup> luminal populations from both <italic>Wnt4</italic>-cKO (<italic>Krt8-CreER;Wnt4<sup>fl/fl</sup></italic>) and control (<italic>Krt8-CreER;Wnt4<sup>fl/+</sup></italic>) mammary gland. qPCR and Western analyses both indicated that loss of Wnt4 increases ERα level in ER<sup>+</sup> luminal cells (<xref ref-type="fig" rid="fig5">Figure 5f–g</xref>), as well as ERα signaling activities showed by increased target gene expression (<xref ref-type="fig" rid="fig5">Figure 5h</xref>). These were in contrast to the reduced <italic>Esr1</italic> level and ERα signaling activity observed in Rspo1-cKO mice (<xref ref-type="fig" rid="fig4">Figure 4i–k</xref>). These were consistent with the in vitro results that Wnt3a and CHIR treatment suppressed <italic>Esr1</italic> expression (<xref ref-type="fig" rid="fig3">Figure 3d</xref>), and consistent with the previous report, in which Wnt-controlled transcriptional regulator LBH repress luminal genes, mainly <italic>Esr1</italic> (<xref ref-type="bibr" rid="bib30">Lindley et al., 2015</xref>). The successful deletion of Wnt4 in cKO group was validated by significantly reduced <italic>Wnt4</italic> level in ER<sup>+</sup> luminal cells (<xref ref-type="fig" rid="fig5">Figure 5e</xref>), as well as reduced expression of Wnt/β-catenin signaling targets <italic>Axin2</italic> and <italic>Lgr5</italic> in basal cells (<xref ref-type="fig" rid="fig5">Figure 5i</xref>). Together, in vivo genetic evidence supports that <italic>Esr1</italic> regulation is independent of luminal Wnt4.</p></sec><sec id="s2-6"><title>Rspo1 relies on cAMP-PKA pathway to induce <italic>Esr1</italic> expression</title><p>To further investigate the downstream mechanisms through which Rspo1/Lgr4 regulate <italic>Esr1</italic>, we conducted an inhibitor-based screen. HEK293T cells with transiently expressing <italic>ESR1</italic>-luciferase reporter were cultured in the presence of RSPO1, and screened for molecules that could suppress luciferase activity using a GPCR inhibitor library (<xref ref-type="fig" rid="fig6">Figure 6a</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). Amongst over 250 inhibitors, the cAMP inhibitor Bupivacaine HCl (Bup), effectively suppressed <italic>ESR1</italic>-luciferase activities induced by RSPO1 (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). Considering that the major downstream effector of cAMP in mammalian cells is Protein Kinase A (PKA), we examined the effect of inhibition of PKA. Consistently, H89, an inhibitor of PKA effectively repressed <italic>ESR1</italic>-luciferase activities induced by RSPO1 (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). The inhibitory effects of Bup and H89 were further examined in primary luminal cell culture. Both inhibitors suppressed <italic>Esr1</italic> expression stimulated by Rspo1 as shown by qPCR (<xref ref-type="fig" rid="fig6">Figure 6b</xref>), but were ineffective on <italic>Axin2</italic> expression (<xref ref-type="fig" rid="fig6">Figure 6c</xref>). Considering the cAMP-PKA pathway can also be activated by estrogen and ERα (<xref ref-type="bibr" rid="bib9">Castoria et al., 2008</xref>), we further examined whether <italic>Esr1</italic> induction by RSPO1 involves ERα. We found that the ERα inhibitor ICI (ICI182, 780) does not affect <italic>ESR1</italic> promoter activities that are induced by RSPO1 (<xref ref-type="fig" rid="fig6">Figure 6d</xref>), suggesting that <italic>Esr1</italic>-induction by Rspo1 does not involve ERα.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Rspo1 inducing <italic>Esr1</italic> expression relies on cAMP-PKA pathway.</title><p>(<bold>a</bold>) HEK293T cells transfected with <italic>ESR1</italic>-luciferase reporter were cultured in the presence of RSPO1, and in combination with pharmaceutical compounds from a GPCR inhibitor library (Selleck). Bupivacaine HCl (Bup), a cAMP inhibitor, and H89, a PKA inhibitor, suppressed <italic>Esr1</italic>-luciferase activities induced by RSPO1 (see <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1a–b</xref>). (<bold>b–c</bold>) qPCR analysis of cultured luminal cells indicating both Bup and H89 counteracted the upregulation of <italic>Esr1</italic> expression induced by RSPO1 (<bold>b</bold>), while <italic>Axin2</italic> expression is not affected (<bold>c</bold>). (<bold>d</bold>) HEK293T cells with transiently expressing <italic>ESR1</italic>-luciferase reporter were cultured in the presence of RSPO1 alone or with ERα inhibitor ICI182, 780. Luciferase activities were measured. ICI did not affect the <italic>ESR1</italic> upregulation induced by RSPO1. (<bold>e</bold>) CRE site on <italic>ESR1</italic> promoter-luciferase reporter was mutated, and RSPO1 could not activate the reporter with CRE mutation. (<bold>f</bold>) RSPO1-FL, RSPO1-R66A/Q71A mutant could, but RSPO1-N137Q and RSPO1-F110A/F106A mutants could not induce <italic>Esr1</italic> promoter luciferase activities. (<bold>g</bold>) ΔLuminescence was read out after Eph4 cells were treated with forskolin (FSR) or RSPO1 for 30 min, ΔLuminescence was calculated as Luminescencetreated—Luminescenceuntreated. Rspo1 treatment induced cAMP production in Eph4 cells in a dose dependent manner. (<bold>h</bold>) Illustration of Rspo1 regulated Esr1 expression mediated by cAMP-PKA pathway. Data in (<bold>a–d</bold>) are pooled from three independent experiments and presented as mean ± s.e.m. Student’s t test: ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05; ns, not significant.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>ESR1-luciferase activities induced by RSPO1 in combination with a GPCR inhibitor library.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-56434-fig6-data1-v1.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title><italic>ESR1</italic>-luciferase activities induced by RSPO1 in combination with a GPCR inhibitor library HEK293 cells with transiently expressing ESR1-luciferase reporter were cultured in the presence of RSPO1, and screened for the molecules that could suppress the luciferase activities using a GPCR inhibitor library (Selleck, L2200).</title><p>Luciferase activities were measured.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-fig6-figsupp1-v1.tif"/></fig></fig-group><p>The transcription factor CREB (cAMP response element binding protein) is the best-characterized nuclear protein that mediates stimulation of transcription by cAMP. CREB binds to the conserved consensus cAMP response element (CRE, sequence <named-content content-type="sequence">TGACATCA</named-content>) (<xref ref-type="bibr" rid="bib39">Rosenberg et al., 2002</xref>). A CRE was found at the proximal promoter of <italic>ESR1</italic> (−991 to −984 bp). Therefore, we examined whether this CRE is responsible for induction of <italic>ESR1</italic> by RSPO1. While RSPO1 induced the wild type promoter-luciferase in a dose-dependent manner, it could not activate the reporter with CRE mutations (<named-content content-type="sequence">TGcCAgCA</named-content>) (<xref ref-type="fig" rid="fig6">Figure 6e</xref>), rendering its specificity. In addition, we co-expressed <italic>ESR1</italic>-luciferase with RSPO1-FL (full length), RSPO1-N137Q (a mutated form with compromising secretion) (<xref ref-type="bibr" rid="bib11">Chang et al., 2016</xref>), RSPO1 F110A/F106A (unable to bind LGR4) (<xref ref-type="bibr" rid="bib47">Wang et al., 2013</xref>), and RSPO1 R66A/Q71A (binds to LGRs but is unable to amplify Wnt signaling) (<xref ref-type="bibr" rid="bib48">Xie et al., 2013</xref>). RSPO1-FL and RSPO1 R66A/Q71A were able to activate the luciferase activities, but RSPO1-N137Q and RSPO1 F110A/F106A could not (<xref ref-type="fig" rid="fig6">Figure 6f</xref>), suggesting the secretion of Rspo1 and its association to LGR4 are critical for <italic>Esr1</italic> transcription. This is in line with the paracrine mechanism we propose. Next, we attempted to directly measure the change of cAMP level upon Rspo1 treatment in mammary Eph4 cells, using Forskolin (FSR) as a positive control. We observed a dose dependent increase of cAMP level in relation to increasing RSPO1 stimulation (<xref ref-type="fig" rid="fig6">Figure 6g</xref>). Together, these results suggest that Rspo1 signals through cAMP-PKA-CREB axis to promote <italic>Esr1</italic> transcription (illustrated in <xref ref-type="fig" rid="fig6">Figure 6h</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we uncover a novel function and signaling mechanism of Rspo1 in promoting ERα expression. This action of Rspo1 is dependent on Lgr4 and G-protein coupled cAMP/PKA pathway, but independent of Wnt/β-catenin signaling. In vivo, the biological significance of this regulatory axis is first revealed in the mammary gland homeostasis. Luminal cells-specific deletion of Rspo1 results decreased ERα expression and reduced side branching.</p><sec id="s3-1"><title>A novel Wnt-independent role of Rspo1</title><p>Rspo1 has been known as a stem cell growth factor in many adult tissues with prominent biological and therapeutic significance. The action of Rspo1 on stem cells is through strongly potentiating Wnt signaling (<xref ref-type="bibr" rid="bib6">Carmon et al., 2011</xref>; <xref ref-type="bibr" rid="bib13">de Lau et al., 2011</xref>; <xref ref-type="bibr" rid="bib15">Glinka et al., 2011</xref>; <xref ref-type="bibr" rid="bib16">Gong et al., 2012</xref>; <xref ref-type="bibr" rid="bib19">Hao et al., 2012</xref>; <xref ref-type="bibr" rid="bib28">Koo et al., 2012</xref>). Here we unveil a new role of Rspo1 in promoting <italic>Esr1</italic> transcription in hormone receptor-positive luminal cells. This Wnt/β-catenin-independent action of Rspo1 relies on the Lgr4 receptor and intracellular cAMP/PKA signaling. Knockdown of Lgr4 counteracts Rspo1’s augmenting effect on ERα transcription in vitro and in vivo, while modulation of Wnt input or β-catenin activity does not affect <italic>Esr1</italic> level induced by Rspo1. Same holds true in vivo when using Wnt4-cKO mouse model. Deletion of <italic>Wnt4</italic> in luminal cells increased <italic>Esr1</italic> level. To our best knowledge, this is the first report of Wnt/β-catenin independent function of Rspo1 in physiological condition. It adds to previous reported Wnt/β-catenin independent role of Rspo1 in antagonizing colon cancer metastasis, in which LGR5 directly binds to TGFβ receptors for the activation of TGFβ signaling (<xref ref-type="bibr" rid="bib51">Zhou et al., 2017</xref>).</p></sec><sec id="s3-2"><title>Rspo1 activates G-protein coupled cAMP signaling in regulating <italic>Esr1</italic></title><p>cAMP is a well-known intracellular mediator of protein hormones including FSH (follicle-stimulating hormone), LH (luteinizing hormone), and TSH (thyroid stimulating hormone), which bind to LGR1, LGR2 and LGR3 respectively (<xref ref-type="bibr" rid="bib14">de Lau et al., 2014</xref>). These known hormone receptors belong to the class-A LGRs. Class-B LGRs, including LRG4-6, are reported to promote phosphorylation of Lrp5/6 and stabilization of β-catenin without the G-protein-coupled cAMP production (<xref ref-type="bibr" rid="bib6">Carmon et al., 2011</xref>; <xref ref-type="bibr" rid="bib13">de Lau et al., 2011</xref>). There have been a few reports that suggest differently, in that Lgr4 activates cAMP/PKA signaling in bone (<xref ref-type="bibr" rid="bib31">Luo et al., 2009</xref>), and in the male reproductive system (<xref ref-type="bibr" rid="bib29">Li et al., 2010</xref>). Independently, our data demonstrate that Rspo1/Lgr4 relies on the cAMP/PKA axis to maintain proper <italic>Esr1</italic> expression during mammary development. This action is highly likely cell type specific. In vivo, either conditional KO of Rspo1 or Lgr4 hypomorphic mutant leads to reduced <italic>Esr1</italic> expression. The latter is in line with previous reports in the male reproductive system, in which deficiency of Lgr4 results in reduced <italic>Esr1</italic> in the efferent ducts and epididymis (<xref ref-type="bibr" rid="bib21">Hoshii et al., 2007</xref>; <xref ref-type="bibr" rid="bib29">Li et al., 2010</xref>). The current study, for the first time, demonstrates that Rspo1 can activate cAMP/PKA signaling.</p></sec><sec id="s3-3"><title>A new hormonal regulation feed forward mechanism</title><p>Our previous studies find that hormones indirectly activate Rspo1 expression in ER<sup>-</sup> luminal cells (<xref ref-type="bibr" rid="bib4">Cai et al., 2014</xref>), and identify Areg (in ER<sup>+</sup> cells) as the intermediate paracrine factor for the hormonal regulation of Rspo1 expression (in ER<sup>-</sup> cells) (<xref ref-type="bibr" rid="bib5">Cai et al., 2020</xref>). Moreover, the elevated levels of Areg and Rspo1 are also detected in estrus, a stage with high estrogen signaling activity (<xref ref-type="bibr" rid="bib5">Cai et al., 2020</xref>). In this study, we found that Rspo1 in turn enhances ERα expression in ER<sup>+</sup> cells. This may represent a feed forward mechanism engaging estrogen-ERα-Rspo1-ERα, highlighting the impact of local growth factors for the amplification of hormonal signaling output. This additional layer of ERα regulation by Rspo1 could be hijacked during tumor initiation or progression. Elucidating the molecular mechanisms on how estrogen engages with ERα in the mammary gland is the key for advancing current knowledge over breast cancer progression and resistance to hormone therapy.</p><p>In conclusion, our study demonstrated a novel Wnt-independent role of Rspo1, revealed a novel Rspo1-Lgr4-cAMP-ERα regulatory axis. As ERα is crucial for the development and diseases of various tissues, this new Rspo1 signaling axis may have broader implication in estrogen-associated diseases.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td><italic>Krt8-CreERT2</italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/22350718">22350718</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:5314229">MGI:5314229</ext-link></td><td>Dr. Li Xin (Department of Molecular and Cellular Biology, Baylor College of Medicine, United States)</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td><italic>Rspo1<sup>flox/+</sup></italic></td><td>This paper</td><td/><td>Generated in our laboratory Detail refer to <xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref></td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td><italic>Wnt4<sup>flox/+</sup></italic></td><td>This paper</td><td/><td>Generated in our laboratory Detail refer to <xref ref-type="fig" rid="fig5">Figure 5</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref></td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td><italic>Lgr4<sup>LacZ/+</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/15192078">15192078</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:3052121">MGI:3052121</ext-link></td><td>Drs. Minyao Liu and Dali Li</td></tr><tr><td>Cell line (<italic>M. musculus</italic>)</td><td>Eph4</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25260709">25260709</ext-link></td><td/><td>Mouse mammary epithelial cell line</td></tr><tr><td>Cell line (<italic>H. sapiens</italic>)</td><td>HEK293T (293T)</td><td><ext-link ext-link-type="uri" xlink:href="http://www.cellbank.org.cn">http://www.cellbank.org.cn</ext-link></td><td valign="bottom">Cat. #: SCSP-502</td><td/></tr><tr><td>Cell line (<italic>H. sapiens</italic>)</td><td>T47D</td><td>Dr. Gaoxiang Ge's laboratory</td><td/><td>Human breast cancer cell line <break/>Dr. Gaoxiang Ge (Institute of Biochemistry and Cell Biology)</td></tr><tr><td>Antibody</td><td>Rabbit anti Gapdh GAPDH Polyclonal Antibody</td><td>Proteintech</td><td>Cat. #: 10494–1-AP <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2263076">AB_2263076</ext-link></td><td>WB (1:3000)</td></tr><tr><td>Antibody</td><td>Mouse anti β-Actin Monoclonal Antibody</td><td>Sigma</td><td>Cat. #: A2228 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_476697">AB_476697</ext-link></td><td>WB (1:2000)</td></tr><tr><td>Antibody</td><td>Rabbit anti ERα Polyclonal Antibody</td><td>Millipore</td><td>Cat. #: 06–935 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_310305">AB_310305</ext-link></td><td>WB (1:1000), IHC (1:200)</td></tr><tr><td>Antibody</td><td>Rat anti Krt8 Monoclonal Antibody</td><td>DSHB</td><td>Cat. #: TROMA-1</td><td>IHC (1:500)</td></tr><tr><td>Antibody</td><td>Rat Anti-Mouse CD31 Monoclonal Antibody, Biotin Conjugated</td><td>BD PharMingen</td><td>Cat. #: 553371 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394817">AB_394817</ext-link></td><td valign="bottom">Flow cytometry (1:200)</td></tr><tr><td>Antibody</td><td>Rat Anti-Mouse CD45 Monoclonal Antibody, Biotin Conjugated</td><td>BD PharMingen</td><td>Cat. #: 553078 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394608">AB_394608</ext-link></td><td valign="bottom">Flow cytometry (1:200)</td></tr><tr><td>Antibody</td><td>Rat Anti-Mouse TER-119 Monoclonal Antibody, Biotin Conjugated</td><td>BD PharMingen</td><td>Cat. #: 553672</td><td valign="bottom">Flow cytometry (1:200)</td></tr><tr><td>Antibody</td><td>Rat Anti-Mouse CD31 Monoclonal Antibody, FITC Conjugated</td><td>BD PharMingen</td><td>Cat. #: 553372 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394818">AB_394818</ext-link></td><td valign="bottom">Flow cytometry (1:200)</td></tr><tr><td>Antibody</td><td>Rat Anti-Mouse CD45 Monoclonal Antibody, FITC Conjugated</td><td>BD PharMingen</td><td>Cat. #: 553080 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394610">AB_394610</ext-link></td><td valign="bottom">Flow cytometry (1:200)</td></tr><tr><td>Antibody</td><td>Rat Anti-Mouse TER119 Monoclonal Antibody, FITC Conjugated</td><td>BD PharMingen</td><td>Cat. #: 557915</td><td valign="bottom">Flow cytometry (1:200)</td></tr><tr><td>Antibody</td><td>PE/Cy7 Rat Anti-Mouse CD24 Monoclonal Antibody</td><td>Biolegend</td><td>Cat. #: 101–822 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_756048">AB_756048</ext-link></td><td valign="bottom">Flow cytometry (1:200)</td></tr><tr><td>Antibody</td><td>APC Armenian Hamster Anti-Mouse/Rat CD29 Monoclonal Antibody</td><td>Biolegend</td><td>Cat. #: 102216 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_492833">AB_492833</ext-link></td><td valign="bottom">Flow cytometry (1:200)</td></tr><tr><td>Antibody</td><td>Rat Anti-Ly-6A/E (Sca-1) Monoclonal Antibody, PE</td><td>eBioscience</td><td>Cat. #: 12-5981-82 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_466086">AB_466086</ext-link></td><td valign="bottom">Flow cytometry (1:200)</td></tr><tr><td>Antibody</td><td>Streptavidin eFluor 450 Conjugate</td><td>eBioscience</td><td>Cat. #: 48-4317-82 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10359737">AB_10359737</ext-link></td><td valign="bottom">Flow cytometry (1:200)</td></tr><tr><td>Peptide, recombinant protein</td><td>Epithelial growth factor (EGF)</td><td>Corning</td><td>Cat. #: 354001</td><td valign="bottom">50 ng/mL</td></tr><tr><td>Peptide, recombinant protein</td><td>FzCRD</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25260709/">25260709</ext-link></td><td/><td>Inhibition of the Frizzled receptor using its soluble CRD domain. Purified in our laboratory (1:200)</td></tr><tr><td>Peptide, recombinant protein</td><td>Wnt3A</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/20569694">20569694</ext-link></td><td/><td>Purified in our laboratory 200 ng/ml</td></tr><tr><td>Recombinant DNA reagent</td><td>plko.1 backbone</td><td>Addgene</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_30323">Addgene_30323</ext-link></td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pGL4.17 basic vector</td><td>Promega, Madison, WI, U.S.A.</td><td>Cat. #: E6721</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pRL-TK Renilla</td><td>Promega, Madison, WI, U.S.A.</td><td>Cat. #: E2241</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pcDNA3.1-RSPO1 overexpression (RSPO1-OE) plasmid</td><td>This paper</td><td/><td>Constructed in our laboratoryDetail refer to Materials and methods</td></tr><tr><td>Chemical compound, drug</td><td>tamoxifen (TAM)</td><td>Sigma-Aldrich</td><td>Cat. #: T5648</td><td>2 mg/20 g</td></tr><tr><td>Chemical compound, drug</td><td>HEPES</td><td>Sigma</td><td>Cat. #: H4034-500G</td><td valign="bottom">25 mM</td></tr><tr><td>Chemical compound, drug</td><td>Collagenase III</td><td>Worthington</td><td>Cat. #: LS004183</td><td valign="bottom">300 U/ml</td></tr><tr><td>Chemical compound, drug</td><td>red blood cell lysing buffer</td><td>Sigma</td><td>Cat. #: R7757</td><td/></tr><tr><td>Chemical compound, drug</td><td>DNase I</td><td>Sigma</td><td>Cat. #: D4263</td><td valign="bottom">0.1 mg/mL</td></tr><tr><td>Chemical compound, drug</td><td>Carmine</td><td>Sigma</td><td>Cat. #: C1022</td><td valign="bottom">2 mg/ml</td></tr><tr><td>Chemical compound, drug</td><td>Histoclear</td><td>National Diagnostics</td><td>Cat. #: HS-200</td><td/></tr><tr><td>Chemical compound, drug</td><td>Matrigel</td><td>BD Bioscience</td><td>Cat. #: 354230</td><td/></tr><tr><td>Chemical compound, drug</td><td>Insulin-Transferrin-Selenium (ITS)</td><td>Gibco</td><td>Cat. #: 41400045</td><td valign="bottom">Cell culture (1:100)</td></tr><tr><td>Chemical compound, drug</td><td>E2</td><td>Sigma</td><td>Cat. #: E8875</td><td valign="bottom">1 μM</td></tr><tr><td>Chemical compound, drug</td><td>IWP2</td><td>Selleck</td><td>Cat. #: s7085</td><td valign="bottom">2.5 μM</td></tr><tr><td>Chemical compound, drug</td><td>CHIR</td><td>Selleck</td><td>Cat. #: S1263</td><td valign="bottom">3 μM</td></tr><tr><td>Chemical compound, drug</td><td>XAV-939</td><td>Selleck</td><td>Cat. #: S1180</td><td valign="bottom">10 μM</td></tr><tr><td>Chemical compound, drug</td><td>Protein A Agarose</td><td>Santa Cruz</td><td>Cat. #: sc-2003</td><td/></tr><tr><td>Chemical compound, drug</td><td>DAPI</td><td>Life Technologies</td><td>Cat. #: P36931</td><td/></tr><tr><td>Chemical compound, drug</td><td>GPCR compound library</td><td>Selleckchem L2200</td><td/><td>Chemical Biology Core Facility, Institute of Biochemistry and Cell Biology, SIBS, CAS</td></tr><tr><td>Commercial assay or kit</td><td>In situ hybridization RNAscope kit</td><td>Advanced Cell Diagnostics</td><td/><td>Following the manufacturer’s instructions</td></tr><tr><td>Commercial assay or kit</td><td>Dual-Luciferase Reporter Assay System</td><td>Promega</td><td>Cat. #: E1910</td><td>Following the manufacturer’s instructions</td></tr><tr><td>Commercial assay or kit</td><td>cAMP-Glo assay kit</td><td>Promega</td><td>Cat. #: V1501</td><td>Following the manufacturer’s instructions</td></tr><tr><td>Commercial assay or kit</td><td>SuperScript III kit</td><td>Invitrogen</td><td>Cat. #: RR036A</td><td>Following the manufacturer’s instructions</td></tr><tr><td>Software, algorithm</td><td>GraphPad Prism</td><td>GraphPad Prism (<ext-link ext-link-type="uri" xlink:href="https://graphpad.com">https://graphpad.com</ext-link>)</td><td/><td/></tr><tr><td>Software, algorithm</td><td>ImageJ</td><td>ImageJ (<ext-link ext-link-type="uri" xlink:href="http://imagej.nih.gov/ij/">http://imagej.nih.gov/ij/</ext-link>)</td><td/><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Experimental animals</title><p><italic>Rspo1<sup>flox/+</sup></italic> and <italic>Wnt4<sup>flox/+</sup></italic> mice were constructed as illustrated in the text. In all conditional knockout experiments, mice were maintained on a C57BL/6 genetic background and at least three animals were analyzed for each genotype. <italic>Lgr4<sup>LacZ/+</sup></italic>(<xref ref-type="bibr" rid="bib33">Mazerbourg et al., 2004</xref>) and <italic>Krt8-CreERT2</italic> (<xref ref-type="bibr" rid="bib49">Zhang et al., 2012a</xref>) strains were used in this study. Nude, CD1 and BALB/c strains were purchased from B and K universal (Shanghai). Animals were housed under conditions of 12 h day/night cycle.</p><p>For Cre recombination induction experiments induced in adult mice, animals received intraperitoneal injection of 2 mg tamoxifen (TAM; Sigma-Aldrich; T5648) diluted in sunflower oil. The Animal Care and Use Committee of Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences approved experimental procedures.</p></sec><sec id="s4-2"><title>Antibodies</title><p>Rabbit anti Gapdh (1:3000; Proteintech; 10494–1-AP), Mouse anti β-Actin (1:2000; Sigma; A2228) and Rabbit anti ERα (1:1000; Millipore; 06–935) were used in Western blot analyses.</p></sec><sec id="s4-3"><title>Primary cell preparation</title><p>Mammary glands from 8- to 12-wk-old virgin female mice were isolated. Minced tissues were placed in digestion buffer (RPMI 1640 [Gibco; C11875500BT] with 25 mM HEPES [Sigma; H4034-500G], 5% FBS [Hyclone], 1% PSQ [Gibco; 15140122], 300 U mL<sup>-</sup>1 Collagenase III [Worthington; LS004183]) and digested for 2 hr at 37°C. After lysis of the red blood cells in red blood cell lysing buffer (Sigma; R7757), a single cell suspension was obtained by sequential incubation with 0.05% Trypsin-EDTA (Gibco; 25300–062) for 5 min at 37°C and 0.1 mg/mL DNase I (Sigma; D4263) for 5 min with gentle pipetting followed by filtration through 70 µm cell strainers (Falcon; 352350).</p></sec><sec id="s4-4"><title>RNA extraction and RNA sequencing</title><p>Total RNA from day two cultured luminal cells (Lin<sup>-</sup>, CD24+, CD29<sup>lo</sup>) were extracted with RNAiso Plus (Takara) following manufacturer’s protocol. Total mRNA concentration was determined with NanoDrop ND-1000 and RNA-seq libraries were prepared according to manufacturer’s instruction (Illumina) followed by applying to sequencing on Illumina nova-seq, which was performed by ANOROAD (<ext-link ext-link-type="uri" xlink:href="http://en.annoroad.com">http://en.annoroad.com</ext-link>, Beijing). Differential gene expression analysis was carried out and genes with significant alteration were extracted and further analysed using DAVID Bioinformatics Resources. RNA-seq data can be viewed online at <ext-link ext-link-type="uri" xlink:href="http://www.biosino.org/node/index">http://www.biosino.org/node/index</ext-link>, under accession number OEP000754.</p></sec><sec id="s4-5"><title>Mammary gland whole mount carmine staining</title><p>The 4th pair of mammary glands were dissected and fixed for 2 hr in 4% paraformaldehyde, and then washed the tissue three times in PBS for 15 min each time. Finally, the tissues were stained in carmine alum solution (2 mg/ml carmine [Sigma; C1022], 5 mg/ml KAl(SO<sub>4</sub>)<sub>2</sub> in H<sub>2</sub>O) overnight at room temperature. After the staining, the tissues were washed in de-staining solution (50% ethanol, 2% HCl) for 2 hr, and then serial dehydrated in 75%, 85%, 95%, 100%, 100% ethanol and finally stored in Histoclear (National Diagnostics; HS-200). Whole mount analyses were performed under a dissection microscope (Leica).</p></sec><sec id="s4-6"><title>Mammary gland whole mount immunostaining</title><p>Whole-mount staining was performed as previously described (<xref ref-type="bibr" rid="bib38">Rios et al., 2014</xref>), with minor modification. In brief, mammary glands were dissected into small pieces, then processed in digestion buffer (RPMI 1640 with 25 mM HEPES, 5% fetal bovine serum, 1% penicillin–streptomycin–glutamine (PSQ), 300 U/ml collagenase III (Worthington)) for 30 min at 37°C, then fixed in 4% paraformaldehyde for 30 min at 4°C. Tissues were incubated with primary antibodies (Krt8; 1:500; DSHB, ER; 1:200; Millipore) at 4°C overnight, followed by washes, incubated with secondary antibodies and DAPI (Life Technologies) at 4°C overnight. Then the tissues were incubated in 80% glycerol overnight, before dissection for 3D imaging. Confocal images were captured using Leica SP8 laser confocal scanning microscope. Representative images were shown in the figures.</p></sec><sec id="s4-7"><title>Cell labeling and flow cytometry</title><p>The following antibodies in 1:200 dilutions were used: biotinylated and FITC conjugated CD31, CD45, and TER119 (BD PharMingen; 553371; 553078; 553672; 553372; 553080; 557915); CD24-PE/cy7, CD29-APC (Biolegend; 101–822; 102216) Sca1-PE and Streptavidin-V450 (eBioscience; 12-5981-82; 48-4317-82). Antibody incubation was performed on ice for 25 min in PBS with 5% FBS. All sorting experiments were performed using a FCAS Jazz (Becton Dickinson). The purity of sorted population was routinely checked and ensured to be &gt;95%.</p></sec><sec id="s4-8"><title>In vitro culture assay</title><p>FACS-sorted cells were resuspended in chilled 100% growth factor-reduced Matrigel (BD Bioscience; 354230), and the mixture was allowed to polymerize before covering with culture medium (DMEM/F12 [Gibco; 11039–021]; ITS [1:100; Gibco; 41400045]; 50 ng mL<sup>-</sup>1 EGF [Corning; 354001]), plus either 1 μM E2 (Sigma; E8875), 200 ng Wnt3A, 1:100 FzCRD, 2.5 μM IWP2 (Selleck; s7085), 3 μM CHIR (Selleck; S1263), 10 μM XAV-939 (Selleck; S1180), Rspo1 purified protein or Wnt4 conditioned media. Culture medium was changed every 24 hr. Cell samples were collected after 2–4 days in culture for RT-qPCR and western blot.</p></sec><sec id="s4-9"><title>Maintenance of cell lines</title><p>293T and Eph4 cell lines were cultured in DMEM high glucose (4.5 g/L) (Gibco, C11995500BT) with 1% Penicillin/Streptomycin (Gibco, 15140) and 10% Fetal bovine serum (FBS) (Hyclone). Both cell lines were cultured in tissue culture dish, kept at 37°C with 5% CO<sub>2</sub>, trypsinized, and split three times a week 1:4. T47D cell line was kindly provided by Dr. Gaoxiang Ge, Institute of Biochemistry and Cell Biology and was cultured in 1640 Medium (Gibco, C11875500BT) +10 mg/ml Insulin with 1% Penicillin/Streptomycin and 10% FBS. All cell lines were routinely negatively tested for mycoplasma.</p></sec><sec id="s4-10"><title>Conditioned media preparation</title><p>Wnt4 conditional medium was prepared by culturing Wnt4-expressing Eph4 cells for 48 hr, followed by supernatant collect. Wnt4 conditional medium was stored at 4°C for short-term storage (up to 1 week). For long-term usage, conditional medium was aliquoted after collection and stored at −80°C.</p></sec><sec id="s4-11"><title>RSPO1 protein purification</title><p>RSPO1-FC construct was cloned into expression vector with a C-terminal Fc tag. RSPO1-FC was transiently expressed in HEK293T cells and medium changed into CD293 medium (Gibco, 11913–019). One day after transfection, medium was collected by centrifugation and incubated with Protein A Agarose Beads (Santa Cruz, sc-2003). The bound recombinant protein was eluted using 500 μl 0.1M Glycine (pH = 3.0) and was collected in 1.5 ml tubes containing 30 ul 1 M Tris-HCl (pH = 9.5) buffer for neutralization. In total 5 tubes of elution were collected. The RSPO1 protein was subsequently purified and concentrated by Centrifugal Filter Volumes (Millipore, UFC803096).</p></sec><sec id="s4-12"><title>Lentiviral vector and infection</title><p>Lgr4-shRNA was synthesized and subcloned into plko backbone with EGFP. Lentivirus was produced by transient transfection in 293 T cells. Mammary cells were isolated from 8- to 12-wk-old virgin female glands as described above, followed by sorting into luminal cells. The sorted cells were collected and cultured in a low adherent plate in EGF, ITS-supplemented DMEM/F12 with virus. At 12 hr after infection, cells were collected and resuspended in Matrigel for consequent in vitro culturing. Sequences of Lgr4-shRNA are <named-content content-type="sequence">CGTAATCAAATCTCCCTGATA</named-content> and <named-content content-type="sequence">CCTCCAGAACAATCAGTTGAA</named-content>.</p></sec><sec id="s4-13"><title>Luciferase assay</title><p>Oligonucleotide primers (nucleotides −1133 to −1107 and −1 to −24 based on previously published sequence information for the upstream region of the <italic>ESR1</italic> were used to generate <italic>ESR1</italic> promoter fragments from normal placental DNA by polymerase chain reaction (PCR) (<xref ref-type="bibr" rid="bib8">Castles et al., 1997</xref>). A 1133 bp (promoter A) of <italic>ESR1</italic> promoter expression vector (ERP) was created by cloning this PCR-generated product into the <italic>XhoI-HindIII</italic> sites of the promoterless luciferase reporter plasmid pGL4.17 basic respectively (Promega, Madison, WI, U.S.A.). Transfections of individual wells were performed using luciferase reporter plasmid (ERP or pGL4.17 basic vector alone), and pRL-TK Renilla luciferase control constructs as a correction for transfection efficiency, and also transfected with pcDNA3.1-RSPO1 overexpression (RSPO1-OE) plasmid (from 0.5 μg/ml to 4 μg/ml)) Cells were then harvested, the dual luciferase assays were performed using a commercial kit (Promega; E1910), Results are shown as fold activity over control activity of the promoterless pGL4.17 basic vector in each set of experiments. All transfections and assays were performed in duplicate with n ≥ 3 individual experiments. GPCR compound library (Selleckchem L2200) was used to for screening of inhibitors that suppress <italic>ESR1</italic> upregulation by RSPO1. In each experiment, <italic>ESR1</italic>-lucieferase reporter cells were treated with RSPO1 for 36–48 hr.</p></sec><sec id="s4-14"><title>In situ hybridization</title><p>In situ hybridization was performed using the RNAscope kit (Advanced Cell Diagnostics) following the manufacturer’s instructions. <italic>Lgr4</italic> probes were ordered from Advanced Cell Diagnostics. For in situ staining, at least three independent experiments were conducted. Representative images are shown in the figures.</p></sec><sec id="s4-15"><title>AMP-Glo assay to detect intracellular cAMP levels</title><p>The intracellular cAMP concentration was measured using the cAMP-Glo assay kit (Promega, V1501) according to the manufacturer’s instruction. The cAMP standard curve was generated using purified cAMP, from which the relative intracellular level of cAMP was inferred. For each drug treatment, three biological repeats were used, and each experiment was repeated 2–3 times.</p></sec><sec id="s4-16"><title>RT-qPCR</title><p>RNA was isolated with Trizol (Invitrogen; 9109). The cDNA library was prepared with the SuperScript III kit (Invitrogen; RR036A). RT–PCR was performed on a StepOne Plus (Applied Biosystems). RNA level was normalized to GAPDH. The primers used were as following:</p><list list-type="simple"><list-item><p>Axin2-F, <named-content content-type="sequence">AGCCTAAAGGTCTTATGTGGCTA</named-content>;</p></list-item><list-item><p>Axin2-R, <named-content content-type="sequence">ACCTACGTGATAAGGATTGACT</named-content>;</p></list-item><list-item><p>Wnt4-F, <named-content content-type="sequence">GCAATTGGCTGTACCTGG</named-content>;</p></list-item><list-item><p>Wnt4-R, <named-content content-type="sequence">GCACTGAGTCCATCACCT</named-content>;</p></list-item><list-item><p>Rspo1-F, <named-content content-type="sequence">GCAACCCCGACATGAACAAAT</named-content>;</p></list-item><list-item><p>Rspo1-R, <named-content content-type="sequence">GGTGCTGTTAGCGGCTGTAG</named-content>;</p></list-item><list-item><p>Esr1-F, <named-content content-type="sequence">TCCAGCAGTAACGAGAAAGGA</named-content></p></list-item><list-item><p>Esr1-R, <named-content content-type="sequence">AGCCAGAGGCATAGTCATTGC</named-content></p></list-item><list-item><p>Pgr-F, <named-content content-type="sequence">GGGGTGGAGGTCGTACAAG</named-content></p></list-item><list-item><p>Pgr-R, <named-content content-type="sequence">GCGAGTAGAATGACAGCTCCTT</named-content></p></list-item><list-item><p>Lgr4-F, <named-content content-type="sequence">AGAACTCAAAGTCCTAACCCTC</named-content></p></list-item><list-item><p>Lgr4-R, <named-content content-type="sequence">ATGCCGCAACTGAACGAG</named-content></p></list-item><list-item><p>Lgr5-F, <named-content content-type="sequence">CCTACTCGAAGACTTACCCAGT</named-content></p></list-item><list-item><p>Lgr5-R, <named-content content-type="sequence">GCATTGGGGTGAATGATAGCA</named-content></p></list-item><list-item><p>Lgr6-F, <named-content content-type="sequence">CTGTAGCCCTGGTGATGA</named-content></p></list-item><list-item><p>Lgr6-R, <named-content content-type="sequence">GGGTTGAAGAGCAGGTAG</named-content></p></list-item><list-item><p>Ctsd1-F, <named-content content-type="sequence">GCTTCCGGTCTTTGACAACCT</named-content></p></list-item><list-item><p>Ctsd1-R, <named-content content-type="sequence">CACCAAGCATTAGTTCTCCTCC</named-content></p></list-item><list-item><p>Wisp2-F, <named-content content-type="sequence">TGTGTGACCAGGCAGTGATG</named-content></p></list-item><list-item><p>Wisp2-R, <named-content content-type="sequence">GTGCTCCAGTTTGGACAGGG</named-content>.</p></list-item></list></sec><sec id="s4-17"><title>Statistical analysis</title><p>One-way ANOVA or Student’s t-test was performed, and the P-value was calculated in Prism on data represented by bar charts, which consisted of results from three independent experiments unless otherwise specified. For all experiments with error bars, the standard deviation (SD) was calculated to indicate the variation within each experiment. No statistical method was used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to Drs. Minyao Liu and Dali Li for kindly sharing of Lgr4<sup>-/-</sup> mice, to Dr. Esther Verheyen for critical reading of the manuscript and Dr. Chi-Chung Hui for helpful suggestion. This work was supported by the Ministry of Science and Technology of China (2019YFA0802002 to YAZ), the National Natural Science Foundation of China (31625020, 31530045, 31830056, 31861163006 to YAZ; 81873532 to QCY; 31671546 to CC), Chinese Academy of Sciences (XDB19020200, XDA16020200 to YAZ) QCY gratefully acknowledges the support of SA-SIBS Scholarship Program.</p> </ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Investigation, Visualization</p></fn><fn fn-type="con" id="con2"><p>Validation, Investigation, Visualization</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Validation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources</p></fn><fn fn-type="con" id="con6"><p>Supervision, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The Animal Care and Use Committee of Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences approved experimental procedures (SIBCB-S335-1601-002-c4).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-56434-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>RNA-seq data can be viewed online at <ext-link ext-link-type="uri" xlink:href="http://www.biosino.org/node/index">http://www.biosino.org/node/index</ext-link>, under accession number OEP000754.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>A Novel Function of R-spondin1</data-title><source>OEP000754</source><pub-id assigning-authority="other" pub-id-type="accession" xlink:href="http://www.biosino.org/node/index">OEP000754</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asselin-Labat</surname> <given-names>M-L</given-names></name><name><surname>Vaillant</surname> <given-names>F</given-names></name><name><surname>Sheridan</surname> <given-names>JM</given-names></name><name><surname>Pal</surname> <given-names>B</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Simpson</surname> <given-names>ER</given-names></name><name><surname>Yasuda</surname> <given-names>H</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Martin</surname> <given-names>TJ</given-names></name><name><surname>Lindeman</surname> <given-names>GJ</given-names></name><name><surname>Visvader</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Control of mammary stem cell function by steroid hormone signalling</article-title><source>Nature</source><volume>465</volume><fpage>798</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1038/nature09027</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname> <given-names>N</given-names></name><name><surname>Huch</surname> <given-names>M</given-names></name><name><surname>Kujala</surname> <given-names>P</given-names></name><name><surname>van de Wetering</surname> <given-names>M</given-names></name><name><surname>Snippert</surname> <given-names>HJ</given-names></name><name><surname>van Es</surname> <given-names>JH</given-names></name><name><surname>Sato</surname> <given-names>T</given-names></name><name><surname>Stange</surname> <given-names>DE</given-names></name><name><surname>Begthel</surname> <given-names>H</given-names></name><name><surname>van den Born</surname> <given-names>M</given-names></name><name><surname>Danenberg</surname> <given-names>E</given-names></name><name><surname>van den Brink</surname> <given-names>S</given-names></name><name><surname>Korving</surname> <given-names>J</given-names></name><name><surname>Abo</surname> <given-names>A</given-names></name><name><surname>Peters</surname> <given-names>PJ</given-names></name><name><surname>Wright</surname> <given-names>N</given-names></name><name><surname>Poulsom</surname> <given-names>R</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro</article-title><source>Cell Stem Cell</source><volume>6</volume><fpage>25</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2009.11.013</pub-id><pub-id pub-id-type="pmid">20085740</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brisken</surname> <given-names>C</given-names></name><name><surname>Heineman</surname> <given-names>A</given-names></name><name><surname>Chavarria</surname> <given-names>T</given-names></name><name><surname>Elenbaas</surname> <given-names>B</given-names></name><name><surname>Tan</surname> <given-names>J</given-names></name><name><surname>Dey</surname> <given-names>SK</given-names></name><name><surname>McMahon</surname> <given-names>JA</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name><name><surname>Weinberg</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling</article-title><source>Genes &amp; Development</source><volume>14</volume><fpage>650</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1101/gad.14.6.650</pub-id><pub-id pub-id-type="pmid">10733525</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>C</given-names></name><name><surname>Yu</surname> <given-names>QC</given-names></name><name><surname>Jiang</surname> <given-names>W</given-names></name><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>Song</surname> <given-names>W</given-names></name><name><surname>Yu</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Zeng</surname> <given-names>YA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>R-spondin1 is a novel hormone mediator for mammary stem cell self-renewal</article-title><source>Genes &amp; Development</source><volume>28</volume><fpage>2205</fpage><lpage>2218</lpage><pub-id pub-id-type="doi">10.1101/gad.245142.114</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>C</given-names></name><name><surname>Geng</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Yu</surname> <given-names>QC</given-names></name><name><surname>Zeng</surname> <given-names>YA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Amphiregulin mediates the hormonal regulation on Rspondin-1 expression in the mammary gland</article-title><source>Developmental Biology</source><volume>458</volume><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2019.10.006</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmon</surname> <given-names>KS</given-names></name><name><surname>Gong</surname> <given-names>X</given-names></name><name><surname>Lin</surname> <given-names>Q</given-names></name><name><surname>Thomas</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/ -catenin signaling</article-title><source>PNAS</source><volume>108</volume><fpage>11452</fpage><lpage>11457</lpage><pub-id pub-id-type="doi">10.1073/pnas.1106083108</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>EJE PRIZE 2016: Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer</article-title><source>European Journal of Endocrinology</source><volume>175</volume><fpage>R41</fpage><lpage>R49</lpage><pub-id pub-id-type="doi">10.1530/EJE-16-0124</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castles</surname> <given-names>CG</given-names></name><name><surname>Oesterreich</surname> <given-names>S</given-names></name><name><surname>Hansen</surname> <given-names>R</given-names></name><name><surname>Fuqua</surname> <given-names>SAW</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Auto-regulation of the estrogen receptor promoter</article-title><source>The Journal of Steroid Biochemistry and Molecular Biology</source><volume>62</volume><fpage>155</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/S0960-0760(97)00023-X</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castoria</surname> <given-names>G</given-names></name><name><surname>Migliaccio</surname> <given-names>A</given-names></name><name><surname>D'Amato</surname> <given-names>L</given-names></name><name><surname>Di Stasio</surname> <given-names>R</given-names></name><name><surname>Ciociola</surname> <given-names>A</given-names></name><name><surname>Lombardi</surname> <given-names>M</given-names></name><name><surname>Bilancio</surname> <given-names>A</given-names></name><name><surname>Di Domenico</surname> <given-names>M</given-names></name><name><surname>de Falco</surname> <given-names>A</given-names></name><name><surname>Auricchio</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Integrating signals between cAMP and MAPK pathways in breast cancer</article-title><source>Frontiers in Bioscience</source><volume>13</volume><fpage>1318</fpage><lpage>1327</lpage><pub-id pub-id-type="doi">10.2741/2764</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chadi</surname> <given-names>S</given-names></name><name><surname>Buscara</surname> <given-names>L</given-names></name><name><surname>Pechoux</surname> <given-names>C</given-names></name><name><surname>Costa</surname> <given-names>J</given-names></name><name><surname>Laubier</surname> <given-names>J</given-names></name><name><surname>Chaboissier</surname> <given-names>M-C</given-names></name><name><surname>Pailhoux</surname> <given-names>E</given-names></name><name><surname>Vilotte</surname> <given-names>J-L</given-names></name><name><surname>Chanat</surname> <given-names>E</given-names></name><name><surname>Le Provost</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>R-spondin1 is required for normal epithelial morphogenesis during mammary gland development</article-title><source>Biochemical and Biophysical Research Communications</source><volume>390</volume><fpage>1040</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2009.10.104</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>C-F</given-names></name><name><surname>Hsu</surname> <given-names>L-S</given-names></name><name><surname>Weng</surname> <given-names>C-Y</given-names></name><name><surname>Chen</surname> <given-names>C-K</given-names></name><name><surname>Wang</surname> <given-names>S-Y</given-names></name><name><surname>Chou</surname> <given-names>Y-H</given-names></name><name><surname>Liu</surname> <given-names>Y-Y</given-names></name><name><surname>Yuan</surname> <given-names>Z-X</given-names></name><name><surname>Huang</surname> <given-names>W-Y</given-names></name><name><surname>Lin</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>Y-H</given-names></name><name><surname>Tsai</surname> <given-names>J-N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>N-Glycosylation of human R-Spondin 1 is required for efficient secretion and stability but not for its heparin binding ability</article-title><source>International Journal of Molecular Sciences</source><volume>17</volume><elocation-id>937</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17060937</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>I</given-names></name><name><surname>Arnaout</surname> <given-names>A</given-names></name><name><surname>Loiseau</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>J</given-names></name><name><surname>Seth</surname> <given-names>A</given-names></name><name><surname>McMahon</surname> <given-names>C</given-names></name><name><surname>Chun</surname> <given-names>K</given-names></name><name><surname>Hennessy</surname> <given-names>B</given-names></name><name><surname>Mills</surname> <given-names>GB</given-names></name><name><surname>Nawaz</surname> <given-names>Z</given-names></name><name><surname>Slingerland</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Src promotes estrogen-dependent estrogen receptor α proteolysis in human breast cancer</article-title><source>Journal of Clinical Investigation</source><volume>117</volume><fpage>2205</fpage><lpage>2215</lpage><pub-id pub-id-type="doi">10.1172/JCI21739</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lau</surname> <given-names>W</given-names></name><name><surname>Barker</surname> <given-names>N</given-names></name><name><surname>Low</surname> <given-names>TY</given-names></name><name><surname>Koo</surname> <given-names>B-K</given-names></name><name><surname>Li</surname> <given-names>VSW</given-names></name><name><surname>Teunissen</surname> <given-names>H</given-names></name><name><surname>Kujala</surname> <given-names>P</given-names></name><name><surname>Haegebarth</surname> <given-names>A</given-names></name><name><surname>Peters</surname> <given-names>PJ</given-names></name><name><surname>van de Wetering</surname> <given-names>M</given-names></name><name><surname>Stange</surname> <given-names>DE</given-names></name><name><surname>van Es</surname> <given-names>J</given-names></name><name><surname>Guardavaccaro</surname> <given-names>D</given-names></name><name><surname>Schasfoort</surname> <given-names>RBM</given-names></name><name><surname>Mohri</surname> <given-names>Y</given-names></name><name><surname>Nishimori</surname> <given-names>K</given-names></name><name><surname>Mohammed</surname> <given-names>S</given-names></name><name><surname>Heck</surname> <given-names>AJR</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling</article-title><source>Nature</source><volume>476</volume><fpage>293</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1038/nature10337</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lau</surname> <given-names>W</given-names></name><name><surname>Peng</surname> <given-names>WC</given-names></name><name><surname>Gros</surname> <given-names>P</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength</article-title><source>Genes &amp; Development</source><volume>28</volume><fpage>305</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1101/gad.235473.113</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glinka</surname> <given-names>A</given-names></name><name><surname>Dolde</surname> <given-names>C</given-names></name><name><surname>Kirsch</surname> <given-names>N</given-names></name><name><surname>Huang</surname> <given-names>YL</given-names></name><name><surname>Kazanskaya</surname> <given-names>O</given-names></name><name><surname>Ingelfinger</surname> <given-names>D</given-names></name><name><surname>Boutros</surname> <given-names>M</given-names></name><name><surname>Cruciat</surname> <given-names>CM</given-names></name><name><surname>Niehrs</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>LGR4 and LGR5 are R-spondin receptors mediating wnt/β-catenin and wnt/PCP signalling</article-title><source>EMBO Reports</source><volume>12</volume><fpage>1055</fpage><lpage>1061</lpage><pub-id pub-id-type="doi">10.1038/embor.2011.175</pub-id><pub-id pub-id-type="pmid">21909076</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>X</given-names></name><name><surname>Carmon</surname> <given-names>KS</given-names></name><name><surname>Lin</surname> <given-names>Q</given-names></name><name><surname>Thomas</surname> <given-names>A</given-names></name><name><surname>Yi</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>LGR6 is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e37137</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0037137</pub-id><pub-id pub-id-type="pmid">22615920</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greicius</surname> <given-names>G</given-names></name><name><surname>Kabiri</surname> <given-names>Z</given-names></name><name><surname>Sigmundsson</surname> <given-names>K</given-names></name><name><surname>Liang</surname> <given-names>C</given-names></name><name><surname>Bunte</surname> <given-names>R</given-names></name><name><surname>Singh</surname> <given-names>MK</given-names></name><name><surname>Virshup</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title><italic>PDGFRα</italic> <sup><italic>+</italic></sup> pericryptal stromal cells are the critical source of Wnts and RSPO3 for murine intestinal stem cells in vivo</article-title><source>PNAS</source><volume>115</volume><fpage>E3173</fpage><lpage>E3181</lpage><pub-id pub-id-type="doi">10.1073/pnas.1713510115</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>XH</given-names></name><name><surname>Jin</surname> <given-names>YR</given-names></name><name><surname>Tan</surname> <given-names>L</given-names></name><name><surname>Kosciuk</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>JS</given-names></name><name><surname>Yoon</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of the follistatin gene by RSPO-LGR4 signaling via activation of the WNT/β-catenin pathway in skeletal myogenesis</article-title><source>Molecular and Cellular Biology</source><volume>34</volume><fpage>752</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1128/MCB.01285-13</pub-id><pub-id pub-id-type="pmid">24344199</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname> <given-names>H-X</given-names></name><name><surname>Xie</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Charlat</surname> <given-names>O</given-names></name><name><surname>Oster</surname> <given-names>E</given-names></name><name><surname>Avello</surname> <given-names>M</given-names></name><name><surname>Lei</surname> <given-names>H</given-names></name><name><surname>Mickanin</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>Ruffner</surname> <given-names>H</given-names></name><name><surname>Mao</surname> <given-names>X</given-names></name><name><surname>Ma</surname> <given-names>Q</given-names></name><name><surname>Zamponi</surname> <given-names>R</given-names></name><name><surname>Bouwmeester</surname> <given-names>T</given-names></name><name><surname>Finan</surname> <given-names>PM</given-names></name><name><surname>Kirschner</surname> <given-names>MW</given-names></name><name><surname>Porter</surname> <given-names>JA</given-names></name><name><surname>Serluca</surname> <given-names>FC</given-names></name><name><surname>Cong</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner</article-title><source>Nature</source><volume>485</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1038/nature11019</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilton</surname> <given-names>HN</given-names></name><name><surname>Clarke</surname> <given-names>CL</given-names></name><name><surname>Graham</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Estrogen and progesterone signalling in the normal breast and its implications for cancer development</article-title><source>Molecular and Cellular Endocrinology</source><volume>466</volume><fpage>2</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2017.08.011</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshii</surname> <given-names>T</given-names></name><name><surname>Takeo</surname> <given-names>T</given-names></name><name><surname>Nakagata</surname> <given-names>N</given-names></name><name><surname>Takeya</surname> <given-names>M</given-names></name><name><surname>Araki</surname> <given-names>K</given-names></name><name><surname>Yamamura</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>LGR4 regulates the postnatal development and integrity of male reproductive tracts in mice</article-title><source>Biology of Reproduction</source><volume>76</volume><fpage>303</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1095/biolreprod.106.054619</pub-id><pub-id pub-id-type="pmid">17079737</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname> <given-names>J-C</given-names></name><name><surname>Rattner</surname> <given-names>A</given-names></name><name><surname>Smallwood</surname> <given-names>PM</given-names></name><name><surname>Nathans</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Biochemical characterization of Wnt-Frizzled interactions using a soluble, biologically active vertebrate Wnt protein</article-title><source>PNAS</source><volume>96</volume><fpage>3546</fpage><lpage>3551</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.7.3546</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>S-MA</given-names></name><name><surname>Mishina</surname> <given-names>YM</given-names></name><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Cheung</surname> <given-names>A</given-names></name><name><surname>Stegmeier</surname> <given-names>F</given-names></name><name><surname>Michaud</surname> <given-names>GA</given-names></name><name><surname>Charlat</surname> <given-names>O</given-names></name><name><surname>Wiellette</surname> <given-names>E</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Wiessner</surname> <given-names>S</given-names></name><name><surname>Hild</surname> <given-names>M</given-names></name><name><surname>Shi</surname> <given-names>X</given-names></name><name><surname>Wilson</surname> <given-names>CJ</given-names></name><name><surname>Mickanin</surname> <given-names>C</given-names></name><name><surname>Myer</surname> <given-names>V</given-names></name><name><surname>Fazal</surname> <given-names>A</given-names></name><name><surname>Tomlinson</surname> <given-names>R</given-names></name><name><surname>Serluca</surname> <given-names>F</given-names></name><name><surname>Shao</surname> <given-names>W</given-names></name><name><surname>Cheng</surname> <given-names>H</given-names></name><name><surname>Shultz</surname> <given-names>M</given-names></name><name><surname>Rau</surname> <given-names>C</given-names></name><name><surname>Schirle</surname> <given-names>M</given-names></name><name><surname>Schlegl</surname> <given-names>J</given-names></name><name><surname>Ghidelli</surname> <given-names>S</given-names></name><name><surname>Fawell</surname> <given-names>S</given-names></name><name><surname>Lu</surname> <given-names>C</given-names></name><name><surname>Curtis</surname> <given-names>D</given-names></name><name><surname>Kirschner</surname> <given-names>MW</given-names></name><name><surname>Lengauer</surname> <given-names>C</given-names></name><name><surname>Finan</surname> <given-names>PM</given-names></name><name><surname>Tallarico</surname> <given-names>JA</given-names></name><name><surname>Bouwmeester</surname> <given-names>T</given-names></name><name><surname>Porter</surname> <given-names>JA</given-names></name><name><surname>Bauer</surname> <given-names>A</given-names></name><name><surname>Cong</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</article-title><source>Nature</source><volume>461</volume><fpage>614</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1038/nature08356</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huch</surname> <given-names>M</given-names></name><name><surname>Dorrell</surname> <given-names>C</given-names></name><name><surname>Boj</surname> <given-names>SF</given-names></name><name><surname>van Es</surname> <given-names>JH</given-names></name><name><surname>Li</surname> <given-names>VSW</given-names></name><name><surname>van de Wetering</surname> <given-names>M</given-names></name><name><surname>Sato</surname> <given-names>T</given-names></name><name><surname>Hamer</surname> <given-names>K</given-names></name><name><surname>Sasaki</surname> <given-names>N</given-names></name><name><surname>Finegold</surname> <given-names>MJ</given-names></name><name><surname>Haft</surname> <given-names>A</given-names></name><name><surname>Vries</surname> <given-names>RG</given-names></name><name><surname>Grompe</surname> <given-names>M</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration</article-title><source>Nature</source><volume>494</volume><fpage>247</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1038/nature11826</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname> <given-names>PA</given-names></name><name><surname>Jackson</surname> <given-names>HW</given-names></name><name><surname>Beristain</surname> <given-names>AG</given-names></name><name><surname>Di Grappa</surname> <given-names>MA</given-names></name><name><surname>Mote</surname> <given-names>PA</given-names></name><name><surname>Clarke</surname> <given-names>CL</given-names></name><name><surname>Stingl</surname> <given-names>J</given-names></name><name><surname>Waterhouse</surname> <given-names>PD</given-names></name><name><surname>Khokha</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Progesterone induces adult mammary stem cell expansion</article-title><source>Nature</source><volume>465</volume><fpage>803</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1038/nature09091</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanaya</surname> <given-names>N</given-names></name><name><surname>Chang</surname> <given-names>G</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Saeki</surname> <given-names>K</given-names></name><name><surname>Bernal</surname> <given-names>L</given-names></name><name><surname>Shim</surname> <given-names>HJ</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Warden</surname> <given-names>C</given-names></name><name><surname>Yamamoto</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Park</surname> <given-names>JS</given-names></name><name><surname>Synold</surname> <given-names>T</given-names></name><name><surname>Vonderfecht</surname> <given-names>S</given-names></name><name><surname>Rakoff</surname> <given-names>M</given-names></name><name><surname>Neuhausen</surname> <given-names>SL</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell RNA-sequencing analysis of estrogen- and endocrine-disrupting chemical-induced reorganization of mouse mammary gland</article-title><source>Communications Biology</source><volume>2</volume><elocation-id>406</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-019-0618-9</pub-id><pub-id pub-id-type="pmid">31701034</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>KA</given-names></name><name><surname>Kakitani</surname> <given-names>M</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Oshima</surname> <given-names>T</given-names></name><name><surname>Tang</surname> <given-names>T</given-names></name><name><surname>Binnerts</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Boyle</surname> <given-names>B</given-names></name><name><surname>Park</surname> <given-names>E</given-names></name><name><surname>Emtage</surname> <given-names>P</given-names></name><name><surname>Funk</surname> <given-names>WD</given-names></name><name><surname>Tomizuka</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mitogenic influence of human R-spondin1 on the intestinal epithelium</article-title><source>Science</source><volume>309</volume><fpage>1256</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1126/science.1112521</pub-id><pub-id pub-id-type="pmid">16109882</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname> <given-names>B-K</given-names></name><name><surname>Spit</surname> <given-names>M</given-names></name><name><surname>Jordens</surname> <given-names>I</given-names></name><name><surname>Low</surname> <given-names>TY</given-names></name><name><surname>Stange</surname> <given-names>DE</given-names></name><name><surname>van de Wetering</surname> <given-names>M</given-names></name><name><surname>van Es</surname> <given-names>JH</given-names></name><name><surname>Mohammed</surname> <given-names>S</given-names></name><name><surname>Heck</surname> <given-names>AJR</given-names></name><name><surname>Maurice</surname> <given-names>MM</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors</article-title><source>Nature</source><volume>488</volume><fpage>665</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1038/nature11308</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>XY</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Sun</surname> <given-names>HY</given-names></name><name><surname>Wang</surname> <given-names>JQ</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>HJ</given-names></name><name><surname>Fan</surname> <given-names>NG</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>JJ</given-names></name><name><surname>Liu</surname> <given-names>RY</given-names></name><name><surname>Li</surname> <given-names>DL</given-names></name><name><surname>Liu</surname> <given-names>MY</given-names></name><name><surname>Ning</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>G protein-coupled receptor 48 upregulates estrogen receptor expression via cAMP/PKA signaling in the male reproductive tract</article-title><source>Development</source><volume>137</volume><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1242/dev.040659</pub-id><pub-id pub-id-type="pmid">20023170</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindley</surname> <given-names>LE</given-names></name><name><surname>Curtis</surname> <given-names>KM</given-names></name><name><surname>Sanchez-Mejias</surname> <given-names>A</given-names></name><name><surname>Rieger</surname> <given-names>ME</given-names></name><name><surname>Robbins</surname> <given-names>DJ</given-names></name><name><surname>Briegel</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The WNT-controlled transcriptional regulator LBH is required for mammary stem cell expansion and maintenance of the basal lineage</article-title><source>Development</source><volume>142</volume><fpage>893</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1242/dev.110403</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>J</given-names></name><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Weng</surname> <given-names>J</given-names></name><name><surname>Yi</surname> <given-names>Z</given-names></name><name><surname>Cho</surname> <given-names>SG</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Yi</surname> <given-names>T</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>X-Y</given-names></name><name><surname>de Crombrugghe</surname> <given-names>B</given-names></name><name><surname>Hook</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Regulation of bone formation and remodeling by G-protein-coupled receptor 48</article-title><source>Development</source><volume>136</volume><fpage>2747</fpage><lpage>2756</lpage><pub-id pub-id-type="doi">10.1242/dev.033571</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macias</surname> <given-names>H</given-names></name><name><surname>Hinck</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mammary gland development</article-title><source>Wiley Interdisciplinary Reviews: Developmental Biology</source><volume>1</volume><fpage>533</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1002/wdev.35</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazerbourg</surname> <given-names>S</given-names></name><name><surname>Bouley</surname> <given-names>DM</given-names></name><name><surname>Sudo</surname> <given-names>S</given-names></name><name><surname>Klein</surname> <given-names>CA</given-names></name><name><surname>Zhang</surname> <given-names>JV</given-names></name><name><surname>Kawamura</surname> <given-names>K</given-names></name><name><surname>Goodrich</surname> <given-names>LV</given-names></name><name><surname>Rayburn</surname> <given-names>H</given-names></name><name><surname>Tessier-Lavigne</surname> <given-names>M</given-names></name><name><surname>Hsueh</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Leucine-rich repeat-containing, G protein-coupled receptor 4 null mice exhibit intrauterine growth retardation associated with embryonic and perinatal lethality</article-title><source>Molecular Endocrinology</source><volume>18</volume><fpage>2241</fpage><lpage>2254</lpage><pub-id pub-id-type="doi">10.1210/me.2004-0133</pub-id><pub-id pub-id-type="pmid">15192078</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meneses-Morales</surname> <given-names>I</given-names></name><name><surname>Tecalco-Cruz</surname> <given-names>AC</given-names></name><name><surname>Barrios-Garcia</surname> <given-names>T</given-names></name><name><surname>Gomez-Romero</surname> <given-names>V</given-names></name><name><surname>Trujillo-Gonzalez</surname> <given-names>I</given-names></name><name><surname>Reyes-Carmona</surname> <given-names>S</given-names></name><name><surname>Garcia-Zepeda</surname> <given-names>E</given-names></name><name><surname>Mendez-Enriquez</surname> <given-names>E</given-names></name><name><surname>Cervantes-Roldan</surname> <given-names>R</given-names></name><name><surname>Perez-Sanchez</surname> <given-names>V</given-names></name><name><surname>Recillas-Targa</surname> <given-names>F</given-names></name><name><surname>Mohar-Betancourt</surname> <given-names>A</given-names></name><name><surname>Leon-Del-Rio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>6885</fpage><lpage>6900</lpage><pub-id pub-id-type="doi">10.1093/nar/gku311</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Planas-Paz</surname> <given-names>L</given-names></name><name><surname>Orsini</surname> <given-names>V</given-names></name><name><surname>Boulter</surname> <given-names>L</given-names></name><name><surname>Calabrese</surname> <given-names>D</given-names></name><name><surname>Pikiolek</surname> <given-names>M</given-names></name><name><surname>Nigsch</surname> <given-names>F</given-names></name><name><surname>Xie</surname> <given-names>Y</given-names></name><name><surname>Roma</surname> <given-names>G</given-names></name><name><surname>Donovan</surname> <given-names>A</given-names></name><name><surname>Marti</surname> <given-names>P</given-names></name><name><surname>Beckmann</surname> <given-names>N</given-names></name><name><surname>Dill</surname> <given-names>MT</given-names></name><name><surname>Carbone</surname> <given-names>W</given-names></name><name><surname>Bergling</surname> <given-names>S</given-names></name><name><surname>Isken</surname> <given-names>A</given-names></name><name><surname>Mueller</surname> <given-names>M</given-names></name><name><surname>Kinzel</surname> <given-names>B</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Mao</surname> <given-names>X</given-names></name><name><surname>Nicholson</surname> <given-names>TB</given-names></name><name><surname>Zamponi</surname> <given-names>R</given-names></name><name><surname>Capodieci</surname> <given-names>P</given-names></name><name><surname>Valdez</surname> <given-names>R</given-names></name><name><surname>Rivera</surname> <given-names>D</given-names></name><name><surname>Loew</surname> <given-names>A</given-names></name><name><surname>Ukomadu</surname> <given-names>C</given-names></name><name><surname>Terracciano</surname> <given-names>LM</given-names></name><name><surname>Bouwmeester</surname> <given-names>T</given-names></name><name><surname>Cong</surname> <given-names>F</given-names></name><name><surname>Heim</surname> <given-names>MH</given-names></name><name><surname>Forbes</surname> <given-names>SJ</given-names></name><name><surname>Ruffner</surname> <given-names>H</given-names></name><name><surname>Tchorz</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size</article-title><source>Nature Cell Biology</source><volume>18</volume><fpage>467</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1038/ncb3337</pub-id><pub-id pub-id-type="pmid">27088858</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajaram</surname> <given-names>RD</given-names></name><name><surname>Buric</surname> <given-names>D</given-names></name><name><surname>Caikovski</surname> <given-names>M</given-names></name><name><surname>Ayyanan</surname> <given-names>A</given-names></name><name><surname>Rougemont</surname> <given-names>J</given-names></name><name><surname>Shan</surname> <given-names>J</given-names></name><name><surname>Vainio</surname> <given-names>SJ</given-names></name><name><surname>Yalcin‐Ozuysal</surname> <given-names>O</given-names></name><name><surname>Brisken</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk</article-title><source>The EMBO Journal</source><volume>34</volume><fpage>641</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.15252/embj.201490434</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regan</surname> <given-names>JL</given-names></name><name><surname>Kendrick</surname> <given-names>H</given-names></name><name><surname>Magnay</surname> <given-names>F-A</given-names></name><name><surname>Vafaizadeh</surname> <given-names>V</given-names></name><name><surname>Groner</surname> <given-names>B</given-names></name><name><surname>Smalley</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer</article-title><source>Oncogene</source><volume>31</volume><fpage>869</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1038/onc.2011.289</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rios</surname> <given-names>AC</given-names></name><name><surname>Fu</surname> <given-names>NY</given-names></name><name><surname>Lindeman</surname> <given-names>GJ</given-names></name><name><surname>Visvader</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>In situ identification of bipotent stem cells in the mammary gland</article-title><source>Nature</source><volume>506</volume><fpage>322</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1038/nature12948</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname> <given-names>D</given-names></name><name><surname>Groussin</surname> <given-names>L</given-names></name><name><surname>Jullian</surname> <given-names>E</given-names></name><name><surname>Perlemoine</surname> <given-names>K</given-names></name><name><surname>Bertagna</surname> <given-names>X</given-names></name><name><surname>Bertherat</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues</article-title><source>Annals of the New York Academy of Sciences</source><volume>968</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2002.tb04327.x</pub-id><pub-id pub-id-type="pmid">12119268</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname> <given-names>T</given-names></name><name><surname>Vries</surname> <given-names>RG</given-names></name><name><surname>Snippert</surname> <given-names>HJ</given-names></name><name><surname>van de Wetering</surname> <given-names>M</given-names></name><name><surname>Barker</surname> <given-names>N</given-names></name><name><surname>Stange</surname> <given-names>DE</given-names></name><name><surname>van Es</surname> <given-names>JH</given-names></name><name><surname>Abo</surname> <given-names>A</given-names></name><name><surname>Kujala</surname> <given-names>P</given-names></name><name><surname>Peters</surname> <given-names>PJ</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche</article-title><source>Nature</source><volume>459</volume><fpage>262</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1038/nature07935</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shackleton</surname> <given-names>M</given-names></name><name><surname>Vaillant</surname> <given-names>F</given-names></name><name><surname>Simpson</surname> <given-names>KJ</given-names></name><name><surname>Stingl</surname> <given-names>J</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Asselin-Labat</surname> <given-names>M-L</given-names></name><name><surname>Wu</surname> <given-names>L</given-names></name><name><surname>Lindeman</surname> <given-names>GJ</given-names></name><name><surname>Visvader</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Generation of a functional mammary gland from a single stem cell</article-title><source>Nature</source><volume>439</volume><fpage>84</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1038/nature04372</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shehata</surname> <given-names>M</given-names></name><name><surname>Teschendorff</surname> <given-names>A</given-names></name><name><surname>Sharp</surname> <given-names>G</given-names></name><name><surname>Novcic</surname> <given-names>N</given-names></name><name><surname>Russell</surname> <given-names>IA</given-names></name><name><surname>Avril</surname> <given-names>S</given-names></name><name><surname>Prater</surname> <given-names>M</given-names></name><name><surname>Eirew</surname> <given-names>P</given-names></name><name><surname>Caldas</surname> <given-names>C</given-names></name><name><surname>Watson</surname> <given-names>CJ</given-names></name><name><surname>Stingl</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland</article-title><source>Breast Cancer Research</source><volume>14</volume><elocation-id>R134</elocation-id><pub-id pub-id-type="doi">10.1186/bcr3334</pub-id><pub-id pub-id-type="pmid">23088371</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigal</surname> <given-names>M</given-names></name><name><surname>Logan</surname> <given-names>CY</given-names></name><name><surname>Kapalczynska</surname> <given-names>M</given-names></name><name><surname>Mollenkopf</surname> <given-names>H-J</given-names></name><name><surname>Berger</surname> <given-names>H</given-names></name><name><surname>Wiedenmann</surname> <given-names>B</given-names></name><name><surname>Nusse</surname> <given-names>R</given-names></name><name><surname>Amieva</surname> <given-names>MR</given-names></name><name><surname>Meyer</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis</article-title><source>Nature</source><volume>548</volume><fpage>451</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1038/nature23642</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleeman</surname> <given-names>KE</given-names></name><name><surname>Kendrick</surname> <given-names>H</given-names></name><name><surname>Robertson</surname> <given-names>D</given-names></name><name><surname>Isacke</surname> <given-names>CM</given-names></name><name><surname>Ashworth</surname> <given-names>A</given-names></name><name><surname>Smalley</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland</article-title><source>Journal of Cell Biology</source><volume>176</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1083/jcb.200604065</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stingl</surname> <given-names>J</given-names></name><name><surname>Eirew</surname> <given-names>P</given-names></name><name><surname>Ricketson</surname> <given-names>I</given-names></name><name><surname>Shackleton</surname> <given-names>M</given-names></name><name><surname>Vaillant</surname> <given-names>F</given-names></name><name><surname>Choi</surname> <given-names>D</given-names></name><name><surname>Li</surname> <given-names>HI</given-names></name><name><surname>Eaves</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Purification and unique properties of mammary epithelial stem cells</article-title><source>Nature</source><volume>439</volume><fpage>993</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1038/nature04496</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanimoto</surname> <given-names>K</given-names></name><name><surname>Eguchi</surname> <given-names>H</given-names></name><name><surname>Yoshida</surname> <given-names>T</given-names></name><name><surname>Hajiro-Nakanishi</surname> <given-names>K</given-names></name><name><surname>Hayashi</surname> <given-names>S-i</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Regulation of estrogen receptor gene mediated by promoter B responsible for its enhanced expression in human breast cancer</article-title><source>Nucleic Acids Research</source><volume>27</volume><fpage>903</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1093/nar/27.3.903</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>D</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Yu</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structural basis for R-spondin recognition by LGR4/5/6 receptors</article-title><source>Genes &amp; Development</source><volume>27</volume><fpage>1339</fpage><lpage>1344</lpage><pub-id pub-id-type="doi">10.1101/gad.219360.113</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>Y</given-names></name><name><surname>Zamponi</surname> <given-names>R</given-names></name><name><surname>Charlat</surname> <given-names>O</given-names></name><name><surname>Ramones</surname> <given-names>M</given-names></name><name><surname>Swalley</surname> <given-names>S</given-names></name><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Rivera</surname> <given-names>D</given-names></name><name><surname>Tschantz</surname> <given-names>W</given-names></name><name><surname>Lu</surname> <given-names>B</given-names></name><name><surname>Quinn</surname> <given-names>L</given-names></name><name><surname>Dimitri</surname> <given-names>C</given-names></name><name><surname>Parker</surname> <given-names>J</given-names></name><name><surname>Jeffery</surname> <given-names>D</given-names></name><name><surname>Wilcox</surname> <given-names>SK</given-names></name><name><surname>Watrobka</surname> <given-names>M</given-names></name><name><surname>LeMotte</surname> <given-names>P</given-names></name><name><surname>Granda</surname> <given-names>B</given-names></name><name><surname>Porter</surname> <given-names>JA</given-names></name><name><surname>Myer</surname> <given-names>VE</given-names></name><name><surname>Loew</surname> <given-names>A</given-names></name><name><surname>Cong</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondin</article-title><source>EMBO Reports</source><volume>14</volume><fpage>1120</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1038/embor.2013.167</pub-id><pub-id pub-id-type="pmid">24165923</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Han</surname> <given-names>SJ</given-names></name><name><surname>Shore</surname> <given-names>AN</given-names></name><name><surname>Rosen</surname> <given-names>JM</given-names></name><name><surname>DeMayo</surname> <given-names>FJ</given-names></name><name><surname>Xin</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>Targeting CreERT2 expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis</article-title><source>Transgenic Research</source><volume>21</volume><fpage>1117</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1007/s11248-012-9598-y</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Bolt</surname> <given-names>M</given-names></name><name><surname>Guertin</surname> <given-names>MJ</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Cherrington</surname> <given-names>BD</given-names></name><name><surname>Slade</surname> <given-names>DJ</given-names></name><name><surname>Dreyton</surname> <given-names>CJ</given-names></name><name><surname>Subramanian</surname> <given-names>V</given-names></name><name><surname>Bicker</surname> <given-names>KL</given-names></name><name><surname>Thompson</surname> <given-names>PR</given-names></name><name><surname>Mancini</surname> <given-names>MA</given-names></name><name><surname>Lis</surname> <given-names>JT</given-names></name><name><surname>Coonrod</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor target gene activation</article-title><source>PNAS</source><volume>109</volume><fpage>13331</fpage><lpage>13336</lpage><pub-id pub-id-type="doi">10.1073/pnas.1203280109</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Geng</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>D</given-names></name><name><surname>Yi</surname> <given-names>H</given-names></name><name><surname>Talmon</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>R-Spondin1/LGR5 activates tgfβ signaling and suppresses Colon cancer metastasis</article-title><source>Cancer Research</source><volume>77</volume><fpage>6589</fpage><lpage>6602</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0219</pub-id><pub-id pub-id-type="pmid">28939678</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.56434.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Reviewing Editor</role><aff><institution>University of Pennsylvania</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Niehrs</surname><given-names>Christof</given-names> </name><role>Reviewer</role><aff><institution>Deutsches Krebsforschungszentrum (DKFZ)</institution><country>Germany</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>De Langhe</surname><given-names>Stijn</given-names> </name><role>Reviewer</role><aff><institution>University of Alabama at Birmingham</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>We are very excited to highlight your studies revealing a novel non-Wnt role for Rspo1 via cAMP-PKA activation. We believe that your studies will expand our understanding of how components of the Wnt pathway act through other non-related pathways.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;A novel function of R-spondin1 in regulating estrogen receptor expression independent of Wnt/β-catenin signaling&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Edward Morrisey as the Senior and Reviewing Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Christof Niehrs (Reviewer #1); Stijn De Langhe (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is 'in revision at <italic>eLife</italic>'. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>In particular, please pay attention to the comments by reviewer 1 and comments 1-3 by reviewer 2. While some of these will require additional data, others may be addressed be a careful editing of the conclusions made in the manuscript.</p><p><italic>Reviewer #1:</italic></p><p>The manuscript by Geng et al., by the Zeng lab uncovers a new role of R-Spondin 1 (Rspo1) for estrogen receptor (<italic>Esr1</italic>) expression in mouse mammary gland. Rspo1 has been exclusively considered as a potent agonist in WNT signaling, where it plays a crucial role in stem cell maintenance and development. Geng and co-authors discovered an unexpected WNT-independent role of Rspo1 in cAMP-PKA signaling to regulate transcription of <italic>Esr1</italic>. The data support a paracrine mechanism involving an Rspo1-<italic>Lgr4</italic>-cAMP-PKA-<italic>Esr1</italic> axis between mammary gland ER+ and ER- cells.</p><p>Overall, this study is nicely designed and executed with a battery of biochemical analyses further supported by genetic evidence in mouse mutants. This study has broad significance for the mammary development, estrogen signaling, Rspo-Lgr, and Wnt signaling fields.</p><p>My only main point concerns the major finding that Rspo1 regulates the cAMP-PKA-<italic>Esr1</italic> axis via <italic>Lgr4</italic>. To better support this conclusion, the authors should provide some additional data:</p><p>1) Figure 4H: For Rspo1 cKO, the authors show Pgr, <italic>Wisp2</italic>, <italic>Ctsd1</italic> and <italic>Cyp1b1</italic> expressions but for the <italic>Lgr4</italic> mutant they only show Pgr and Greb1 (Supplementary Figure 4C). The authors should also check <italic>Wisp2</italic>, <italic>Ctsd1</italic> and <italic>Cyp1b1</italic> expressions in <italic>Lgr4</italic> mutant, to test if these markers show the same trend of Rspo1 cKO, to better demonstrate that Rspo1 and <italic>Lgr4</italic> cooperates for regulating <italic>Esr1</italic> transcription.</p><p>2) Figure 4: The authors should perform a western blot or immunofluorescence of ERα in <italic>Lgr4</italic> lof cells, as they did with Rspo1 cKO (4i,g).</p><p><italic>Reviewer #2:</italic></p><p>Dr. Zeng's group previously reported that estrogen and progesterone signaling could activate RSPO1 and that RSPO1 and <italic>Wnt4</italic> synergize to promote mammary stemness. In this manuscript, the authors studied the effect of RSPO1 on modulating <italic>Esr1</italic> transcription and ERα signaling. They observed that RSPO1 can induce <italic>Esr1</italic> expression in cultured mammary cells, and went on to show that RSPO1 affects <italic>Esr1</italic> expression in mammary cells through LGR4-cAMP-PKA-CREB but independent of Wnt signaling. Demonstrating a Wnt signaling-independent effect on <italic>Esr1</italic> transaction is significant as RSPO1 is primarily known to bind LGR4/5/6 to potentiate Wnt signaling. However, LGR4 has been reported previously to activate <italic>Esr1</italic> in non-mammary cells and via cAMP-PKA-CREB cells as cited in the Discussion. Furthermore, this work is largely preliminary based on cultures of cells isolated from mice and primarily one single mouse cell line Eph4. The direct in vivo evidence is weak. Therefore, while it is important to study how RSPO1 regulates <italic>Esr1</italic> in mammary cells, this manuscript did not make a significant further advance beyond what is already published. Main concerns are listed below:</p><p>1) The in vivo evidence that RSPO1 regulates <italic>Esr1</italic> expression in mammary cells is weak. The authors generated a Rspo1 conditional KO mouse line. In comparing the <italic>Esr1</italic> expression between WT and KO mice, the authors showed a tangential cut of a duct rather than a typical duct with lumen (Figure 4G), and they failed to quantify and compare these immunofluorescence-stained ducts. Such quantification would have provided much needed in vivo evidence. Instead, the authors chose to isolate a subset of mammary cells for qPCR for ERα transcriptional targets and ERα Western blotting. However, RSPO1 may have changed the cell fate, and the isolated cells from the KO mice could be a skewed subset, unsuitable for comparison with the WT cell preparations. Furthermore, the ERα Western lacked statistical consideration, and <italic>Esr1</italic> qPCR was not performed.</p><p>2) To support their claim that RSPO1 regulates <italic>Esr1</italic> independent of Wnt signaling, they presented in vitro data (Figure 3) that suppressing Wnt signaling could not dampen RSPO1 effects on <italic>Esr1</italic> expression while activating Wnt signaling suppressed <italic>Esr1</italic> expression. Next, they generated a tamoxifen induced knockout line of <italic>Wnt4</italic> (Figure 5). It is bewildering that the authors did not carefully examine the ER expression in the mammary glands from these mice. Rather they only performed qPCR analysis of a subset of mammary cells isolated from conditional <italic>Wnt4</italic> KO mice, which suffers the same flaw as above. The qPCR indeed showed decreased <italic>Esr1</italic> expression, but the Figure 5 legend states that &quot;Loss of <italic>Wnt4</italic> does not affect <italic>Esr1</italic> expression in luminal cells,&quot; leading this reviewer to wonder what exactly the authors attempted to prove. Furthermore, any observation of knockout of a single member of the large Wnt gene family on <italic>Esr1</italic> expression cannot be extrapolated to support the claim that RSPO1 activation of <italic>Esr1</italic> expression does not require Wnt signaling. In addition, it is a huge stretch to cite Lindley et al., 2015 to claim that Wnt/catenin has been reported to suppress ER when the cited paper only showed LBH can regulate ER. LBH is one of the hundreds of target genes that may be regulated by Wnt signaling in various contexts. Not every function of these huge family of target genes can be extrapolated as Wnt signaling effects.</p><p>3) In addition to RSPO1-N137Q in Figure 6F, the authors should test other RSPO1 mutants in inducing <italic>Esr1</italic> expression, including RSPO1 F110A/F106A (which could not bind to LGR4) and RSPO1 R66A/Q71A (which could bind to LGR4 but could not amplify Wnt signaling). These experiments are important as positive data would provide direct evidence that LGR4 but not activation of Wnt/β-catenin signaling is required for RSPO1 in inducing <italic>Esr1</italic> expression.</p><p>4) The authors presented evidence that RSPO1 can modulate cAMP-PKA-CREB to transactivate <italic>Esr1</italic>; however, the authors cannot make the jump that RSPO1 does this via LGR4 and independent of Wnt signaling. These authors did not test in their own cell lines whether LGR4 is required for this RSPO1 regulation of cAMP-PKA-CREB and whether the G protein activities of LGR4 are involved in <italic>Esr1</italic> expression.</p><p>5) While it is reasonable to isolate ERα positive mammary cells for testing the effect of RSPO1, the data would have been much more convincing if they also included ERα-negative cells as a control and showed no induction of ERα. The authors also did not explain why RSPO1 needs to act by a paracrine manner to activate LGR4 to activate <italic>Esr1</italic> expression. What prevents RSPO1 from activating LGR4 on the RSPO1-producing cells?</p><p>6) Only one shRNA against LGR4 is used. It is uncertain that the observed effects on <italic>Esr1</italic> are not due to off-target targets. This is especially grave in Figure 2E which shows that this LGR4 shRNA can suppress <italic>Esr1</italic> in MCF7 cells, which has been reported to have very low levels of LGR4.</p><p>7) It is unclear whether RSPO1 affects Wnt signaling in their experiment models. In Figure 3A, RSPO1 treatment of mammary cells in vitro did not affect <italic>Axin2</italic> mRNA levels. However, in Figure 3C, RSPO1 alone significantly enhanced <italic>Axin2</italic> mRNA levels. There is no explanation for this discrepancy. The authors did not show whether their conditional RSPO1 knockout mice impacted Wnt signaling.</p><p><italic>Reviewer #3:</italic></p><p>This is an elegantly performed study demonstrating a novel function of R-spondin1 in regulating estrogen receptor expression independent of Wnt/β-catenin signaling.</p><p>I have no concerns.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.56434.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>[…] My only main point concerns the major finding that Rspo1 regulates the cAMP-PKA-Esr1 axis via Lgr4. To better support this conclusion, the authors should provide some additional data:</p><p>1) Figure 4H: For Rspo1 cKO, the authors show Pgr, Wisp2, Ctsd1 and Cyp1b1 expressions but for the Lgr4 mutant they only show Pgr and Greb1 (Supplementary Figure 4C). The authors should also check Wisp2, Ctsd1 and Cyp1b1 expressions in Lgr4 mutant, to test if these markers show the same trend of Rspo1 cKO, to better demonstrate that Rspo1 and Lgr4 cooperates for regulating Esr1 transcription.</p></disp-quote><p>Following the reviewer’s suggestion, we performed qPCR analysis for <italic>Wisp2, Ctsd1</italic> and <italic>Cyp1b1</italic> and have included the data into revised Figure 4—figure supplement 2E. Consistent with the decrease seen in Rspo1-cKO, expression of <italic>Wisp2</italic> and <italic>Ctsd1</italic> also reduced in <italic>Lgr4</italic> mutant. We did not included <italic>Cyp1b1</italic>, as its expression level was very low, therefore its change may not be a proper indication of ERα signaling activities. For similar reason, we also removed <italic>Cyp1b1</italic> data from revised Figure 4K.</p><disp-quote content-type="editor-comment"><p>2) Figure 4: The authors should perform a western blot or immunofluorescence of ERα in Lgr4 lof cells, as they did with Rspo1 cKO (Figure 4G, I).</p></disp-quote><p>Following the suggestion, we performed immunofluorescent staining of ERα in control (<italic>Lgr4<sup>+/-</sup></italic>) and <italic>Lgr4<sup>-/-</sup></italic> mutant mammary sections (revised Figure 4—figure supplement 2C, D). As expected, the proportion of ERα+ luminal cell was decreased in <italic>Lgr4<sup>-/-</sup></italic>, in line with the decrease seen in Rspo1-cKO.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>Dr. Zeng's group previously reported that estrogen and progesterone signaling could activate RSPO1 and that RSPO1 and Wnt4 synergize to promote mammary stemness. In this manuscript, the authors studied the effect of RSPO1 on modulating Esr1 transcription and ERα signaling. They observed that RSPO1 can induce Esr1 expression in cultured mammary cells, and went on to show that RSPO1 affects Esr1 expression in mammary cells through LGR4-cAMP-PKA-CREB but independent of Wnt signaling. Demonstrating a Wnt signaling-independent effect on Esr1 transaction is significant as RSPO1 is primarily known to bind LGR4/5/6 to potentiate Wnt signaling. However, LGR4 has been reported previously to activate Esr1 in non-mammary cells and via cAMP-PKA-CREB cells as cited in the Discussion. Furthermore, this work is largely preliminary based on cultures of cells isolated from mice and primarily one single mouse cell line Eph4. The direct in vivo evidence is weak. Therefore, while it is important to study how RSPO1 regulates Esr1 in mammary cells, this manuscript did not make a significant further advance beyond what is already published. Main concerns are listed below:</p><p>1) The in vivo evidence that RSPO1 regulates Esr1 expression in mammary cells is weak. The authors generated a Rspo1 conditional KO mouse line. In comparing the Esr1 expression between WT and KO mice, the authors showed a tangential cut of a duct rather than a typical duct with lumen (Figure 4G), and they failed to quantify and compare these immunofluorescence-stained ducts. Such quantification would have provided much needed in vivo evidence. Instead, the authors chose to isolate a subset of mammary cells for qPCR for ERα transcriptional targets and ERα Western blotting. However, RSPO1 may have changed the cell fate, and the isolated cells from the KO mice could be a skewed subset, unsuitable for comparison with the WT cell preparations. Furthermore, the ERα Western lacked statistical consideration, and Esr1 qPCR was not performed.</p></disp-quote><p>We respectfully disagree with the reviewer. The wholemount immunostaining shown in Figure 4G (the reviewer referred as &quot;a tangible cut&quot;) provides a broader view compared to the traditional cross section. In our opinion, whole mount immunostaining is a technical advance that better demonstrates the distribution/density of ERα+ cells along the mammary duct, which cross section fails to achieve. Following the suggestion, we included quantification data showing that decreased percentage of ERα+ cells (revised Figure 4H).</p><p>I hope the reviewer agrees that, based on the above observation, performing qPCR or WB using total luminal cells would merely confirm the decreased percentage of ERα+ cells, instead of providing further information.</p><p>In our opinion, the above quantification likely reflects the overall reduction of ERα level in luminal compartment. Although we could not exclude the possible switching of ER+ to ER- cell fate due to other indirect reasons, we tested a more direct possibility—whether it is the reduction of ERα expression in ER+ compartment that results in loss of ER+ cells. To this end, we isolated ER+ luminal cells (Lin<sup>-</sup>, CD24<sup>+</sup>, CD29<sup>lo</sup>, Sca1<sup>+</sup>), and analyzed ERα levels as well as ERα signaling activities. We were able to show that on top of decreased percentage of ERα+ cells, the remaining ERα+ cells also displayed reduced ERα level and compromised ERα signaling activities (Figure 4I-K). The loss of ERα+ cells (Figure 4G-H) and the reduction in ERα level in the remaining ERα+ cells (Figure 4J) likely reflect different extents of Rspo1 regulation over ERα+ expression.</p><p>Following the suggestion, we have included the qPCR analysis of <italic>Esr1</italic> (revised Figure 4I).</p><disp-quote content-type="editor-comment"><p>2) To support their claim that RSPO1 regulates Esr1 independent of Wnt signaling, they presented in vitro data (Figure 3) that suppressing Wnt signaling could not dampen RSPO1 effects on Esr1 expression while activating Wnt signaling suppressed Esr1 expression. Next, they generated a tamoxifen induced knockout line of Wnt4 (Figure 5). It is bewildering that the authors did not carefully examine the ER expression in the mammary glands from these mice. Rather they only performed qPCR analysis of a subset of mammary cells isolated from conditional Wnt4 KO mice, which suffers the same flaw as above. The qPCR indeed showed decreased Esr1 expression, but the Figure 5 legend states that &quot;Loss of Wnt4 does not affect Esr1 expression in luminal cells,&quot; leading this reviewer to wonder what exactly the authors attempted to prove. Furthermore, any observation of knockout of a single member of the large Wnt gene family on Esr1 expression cannot be extrapolated to support the claim that RSPO1 activation of Esr1 expression does not require Wnt signaling. In addition, it is a huge stretch to cite Lindley et al., 2015 to claim that Wnt/catenin has been reported to suppress ER when the cited paper only showed LBH can regulate ER. LBH is one of the hundreds of target genes that may be regulated by Wnt signaling in various contexts. Not every function of these huge family of target genes can be extrapolated as Wnt signaling effects.</p></disp-quote><p>We respectfully disagree with the reviewers. As explained above, using isolated ER+ luminal cells to examine ER signaling is a more stringent experimental design in our opinion. But we understand the reviewer’s concern, thus we also performed qPCR using whole luminal cells from control and <italic>Wnt4</italic>-cKO mice, which confirmed that loss of <italic>Wnt4</italic> increases <italic>Esr1</italic> expression and ER signaling activities (see <xref ref-type="fig" rid="respfig1">Author response image 1</xref>).</p><fig id="respfig1"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-resp-fig1-v1.tif"/></fig><p>Our apologies that the title in Figure 5 caused confusion. We have modified it to “Loss of <italic>Wnt4</italic> increases <italic>Esr1</italic> expression in luminal cells”.We respectfully disagree with the reviewers regarding the issue of overstatement when describing the effect of <italic>Wnt4</italic>. In Figure 3, when we concluded that “<italic>Esr1</italic> expression induced by Rspo1 is independent of Wnt/β-catenin signaling”, aside from <italic>Wnt4</italic>, we used activators Wnt3a and CHIR, and inhibitors FzCRD and XAV939. Those results collectively supported our conclusion. Subsequently, in Figure 5, we used <italic>Wnt4</italic>-cKO as a genetic model for in vivo validation, considering that <italic>Wnt4</italic> is the major Wnt member in adult mammary epithelium, and that <italic>Wnt4</italic>/Rspo1 synergy has been reported in the mammary gland. In our opinion, our subtitle, “Genetic evidence supports that <italic>Esr1</italic> regulation is independent of luminal <italic>Wnt4</italic>” was precise, and did not extend to refer other Wnt/β-catenin signaling.</p><p>Regarding how to cite the Lindley et al., 2015 paper, it has been rephrased to “…consistent with the previous report, in which Wnt-controlled transcriptional regulator LBH repress luminal genes, mainly <italic>Esr1</italic> (Lindley et al., 2015).” Of note, “Wnt-controlled transcriptional regulator LBH” is the exact word used in the title of Lindley et al., 2015.</p><disp-quote content-type="editor-comment"><p>3) In addition to RSPO1-N137Q in Figure 6F, the authors should test other RSPO1 mutants in inducing Esr1 expression, including RSPO1 F110A/F106A (which could not bind to LGR4) and RSPO1 R66A/Q71A (which could bind to LGR4 but could not amplify Wnt signaling). These experiments are important as positive data would provide direct evidence that LGR4 but not activation of Wnt/β-catenin signaling is required for RSPO1 in inducing Esr1 expression.</p></disp-quote><p>We thank the reviewer for the suggestion, and performed the experiments accordingly. As shown in revised Figure 6F, both RSPO1-N137Q mutant (prevents RSPO1 secretion) and RSPO1-F110A/F106A mutant (unable to bind to LGR4) abolished RSPO1's ability to activate <italic>Esr1</italic> luciferase reporter, while treatment with RSPO1-R66A/Q71A mutant (could not amplify Wnt signaling) showed similar <italic>Esr1</italic> luciferase activation as treatment with wildtype RSPO1. These results further supported that Wnt/β-catenin signaling is not required for <italic>Esr1</italic>-induction by Rspo1.</p><disp-quote content-type="editor-comment"><p>4) The authors presented evidence that RSPO1 can modulate cAMP-PKA-CREB to transactivate Esr1; however, the authors cannot make the jump that RSPO1 does this via LGR4 and independent of Wnt signaling. These authors did not test in their own cell lines whether LGR4 is required for this RSPO1 regulation of cAMP-PKA-CREB and whether the G protein activities of LGR4 are involved in Esr1 expression.</p></disp-quote><p>We apologize for the confusion caused. The requirement for <italic>Lgr4</italic> in Rspo1 induced <italic>Esr1</italic> expression has been shown in primary luminal cells (Figure 2D) and in T47D cells (Figure 2E). The connection of Rspo1 to cAMP-PKA-CREB-<italic>Esr1</italic> is revealed in Figure 6 as the reviewer pointed out. The connection of <italic>Lgr4</italic> to cAMP-PKA is known<sup>1-3</sup>. Together, in our opinion, it is logical to propose such a signaling model.</p><disp-quote content-type="editor-comment"><p>5) While it is reasonable to isolate ERα positive mammary cells for testing the effect of RSPO1, the data would have been much more convincing if they also included ERα-negative cells as a control and showed no induction of ERα. The authors also did not explain why RSPO1 needs to act by a paracrine manner to activate LGR4 to activate Esr1 expression. What prevents RSPO1 from activating LGR4 on the RSPO1-producing cells?</p></disp-quote><p>We thank the reviewer for the suggestion. We isolated ER- luminal cells and cultured them in the presence of RSPO1 for 2 days. Treatment of RSPO1 to ER- luminal cells didn’t result in significant change in <italic>Esr1</italic> expression. We have included this result in revised Figure 1—figure supplement 1C.</p><p>The reviewer raised an interesting point. At this stage, we don’t know what prevents Rspo1 from acting on ER- cells. It could be the intrinsic mechanism of ER- cells, which is a subject of future study.</p><disp-quote content-type="editor-comment"><p>6) Only one shRNA against LGR4 is used. It is uncertain that the observed effects on Esr1 are not due to off-target targets. This is especially grave in Figure 2E which shows that this LGR4 shRNA can suppress Esr1 in MCF7 cells, which has been reported to have very low levels of LGR4.</p></disp-quote><p>Following the suggestions, we generated one additional shRNA and replaced MCF7 cells with T47D cells that have higher LGR4 expression. We confirmed that both shRNAs (sh1 and sh2) are efficient in reducing endogenous <italic>LGR4</italic> expression in T47D cells (revised Figure 2—figure supplement 1), and produce consistent results in eliminating RSPO1 induced <italic>Esr1</italic>-luciferase reporter activities (Revised Figure 2E).</p><disp-quote content-type="editor-comment"><p>7) It is unclear whether RSPO1 affects Wnt signaling in their experiment models. In Figure 3A, RSPO1 treatment of mammary cells in vitro did not affect Axin2 mRNA levels. However, in Figure 3C, RSPO1 alone significantly enhanced Axin2 mRNA levels. There is no explanation for this discrepancy. The authors did not show whether their conditional RSPO1 knockout mice impacted Wnt signaling.</p></disp-quote><p>We apologize for the confusion caused. We have incorporated more repeats in revised Figure 3C, and our combined dataset suggest there is no significant change in <italic>Axin2</italic> expression after RSPO1 treatments.</p><p>Our RSPO1-cKO indeed resulted in decreased Wnt signaling activities in basal cells (see <xref ref-type="fig" rid="respfig2">Author response image 2</xref>). Control and RSPO1-cKO mice were administered with tamoxifen at 8-week-old and mammary glands were harvested after 4 weeks. Basal cells were isolated for qPCR analysis. We found that the expressions of Wnt target genes, <italic>Axin2</italic> and <italic>Lgr5</italic>, are reduced.</p><fig id="respfig2"><label>Author response image 2.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56434-resp-fig2-v1.tif"/></fig><p>References:1) Luo, J. et al. Regulation of bone formation and remodeling by G-protein-coupled receptor 48. Development 136, 2747-2756, doi:10.1242/dev.033571 (2009).2) Du, B. et al. Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression. J Biol Chem 288, 15131-15141, doi:10.1074/jbc.M113.455535 (2013).3) Weng, J. et al. Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2. Proc Natl Acad Sci U S A 105, 6081-6086, doi:10.1073/pnas.0708257105 (2008).</p></body></sub-article></article>